If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 696.40
Bid: 696.40
Ask: 696.60
Change: -24.40 (-3.39%)
Spread: 0.20 (0.029%)
Open: 700.00
High: 701.10
Low: 696.40
Prev. Close: 720.80
HSBA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report - Part 5

21 Feb 2024 16:31

RNS Number : 9447D
HSBC Holdings PLC
21 February 2024
 

Wholesale analysis

IFRS 9 ECL sensitivity to future economic conditions1,2,3

Reported Gross carrying amount4

Reported allowance for ECL

Consensus Central scenario allowance for ECL

Consensus Upside scenario allowance for ECL

Consensus Downside scenario allowance for ECL

Downside 2 scenario allowance for ECL

By geography at 31 Dec 2023

$m

$m

$m

$m

$m

$m

UK

426,427 

820 

754 

599 

1,041 

2,487 

US

191,104 

215 

199 

189 

268 

441 

Hong Kong

447,480 

609 

566 

433 

807 

1,393 

Mainland China

129,945 

258 

217 

142 

414 

945 

Canada5

84,092 

89 

75 

56 

107 

487 

Mexico

30,159 

60 

56 

46 

73 

226 

UAE

52,074 

32 

32 

30 

34 

40 

France

178,827 

98 

102 

90 

124 

141 

Other geographies6

450,271 

325 

298 

245 

410 

882 

Total

1,990,378

2,507 

2,301 

1,829 

3,278 

7,043 

of which:

Stage 1

1,820,843

754 

702 

553 

860 

854 

Stage 2

169,535 

1,753 

1,599 

1,276 

2,418 

6,189 

 

By geography at 31 Dec 2022

UK

421,685 

769 

624 

484 

833 

2,240 

US

190,858 

277 

241 

227 

337 

801 

Hong Kong

415,875 

925 

819 

592 

1,315 

2,161 

Mainland China

125,466 

295 

242 

144 

415 

1,227 

Canada5

83,274 

126 

80

60

148 

579 

Mexico

26,096 

88

80

67

116 

313 

UAE

45,064 

45

41

30

55

93

France

173,146 

110 

102 

90

121 

145 

Other geographies6

445,758 

447 

384 

304 

527 

1,054 

Total

1,927,222 

3,083 

2,612 

2,000 

3,866 

8,612 

1 Allowance for ECL sensitivity includes off-balance sheet financial instruments. These are subject to significant measurement uncertainty.

2 Includes low credit-risk financial instruments such as debt instruments at FVOCI, which have high carrying amounts but low ECL under all the above scenarios.

3 Excludes defaulted obligors. For a detailed breakdown of performing and non-performing wholesale portfolio exposures, see page 176.

4 Staging refers only to probability-weighted/reported gross carrying amount. Stage allocation of gross exposures varies by scenario, with higher allocation to stage 2 under the Downside 2 scenario.

5 Classified as held for sale at 31 December 2023 and 31 December 2022.

6 Includes small portfolios that use less complex modelling approaches and are not sensitive to macroeconomic changes.

 

At 31 December 2023, the highest level of 100% scenario-weighted allowance for ECL was observed in the UK and Hong Kong. This higher ECL impact was largely driven by significant exposure in these regions.

Compared with 31 December 2022, the Downside 2 allowance for ECL was lower in Hong Kong and mainland China, mostly due to the crystallisation of defaults for certain high-risk exposures and a decrease of the associated downside uncertainty.

 

In the wholesale portfolio, off-balance sheet financial instruments have a lower likelihood to be fully converted to a funded exposure at the point of default, and consequently the sensitivity of the allowance for ECL is lower in relation to its nominal amount, when compared with an on-balance sheet exposure with a similar risk profile.

 

Retail analysis

IFRS 9 ECL sensitivity to future economic conditions1

Reported gross carrying amount

Reported allowance for ECL

Consensus Central scenario allowance for ECL

Consensus Upside scenario allowance for ECL

Consensus Downside scenario allowance for ECL

Downside 2 scenario allowance for ECL

By geography at 31 December 2023

$m

$m

$m

$m

$m

$m

UK

Mortgages

161,127 

189 

180 

172 

201 

334 

Credit cards

7,582 

344 

340 

302 

353 

486 

Other

8,183 

341 

333 

273 

383 

515 

Mexico

Mortgages

8,666 

188 

180 

150 

235 

363 

Credit cards

2,445 

295 

286 

206 

376 

489 

Other

4,529 

513 

503 

426 

600 

731 

Hong Kong

Mortgages

106,136 

Credit cards

9,128 

287 

239 

214 

395 

887 

Other

6,269 

109 

100 

88 

124 

256 

UAE

Mortgages

2,001 

25 

25 

25 

25 

25 

Credit cards

471 

24 

24 

22 

25 

32 

Other

721 

20 

20 

19 

21 

28 

France3

Mortgages

20,589 

50 

50 

50 

51 

51 

Other

1,328 

44 

44 

43 

45 

48 

US

Mortgages

14,385 

10 

Credit cards

204 

15 

15 

10 

15 

16 

Canada2

Mortgages

25,464 

67 

65 

64 

70 

99 

Credit cards

338 

13 

13 

12 

16 

15 

Other

1,368 

13 

13 

12 

14 

33 

Other geographies

Mortgages

55,368 

152 

149 

144 

158 

198 

Credit cards

3,655 

173 

166 

151 

202 

291 

Other

2,416 

91 

86 

83 

95 

137 

Total

442,373 

2,962 

2,835 

2,471 

3,411 

5,049 

of which: mortgages

Stage 1

347,874 

101 

92 

77 

145 

303 

Stage 2

43,451 

264 

249 

225 

280 

429 

Stage 3

2,412 

316 

314 

307 

322 

352 

of which: credit cards

Stage 1

18,557 

249 

232 

180 

329 

604 

Stage 2

4,953 

707 

657 

546 

859 

1,415 

Stage 3

312 

193 

193 

192 

194 

197 

of which: others

Stage 1

19,551 

218 

151 

205 

272 

501 

Stage 2

4,542 

540 

423 

519 

636 

868 

Stage 3

722 

373 

370 

373 

375 

379 

 

IFRS 9 ECL sensitivity to future economic conditions1 (continued)

Reported gross carrying amount

Reported allowance for ECL

Consensus Central scenario allowance for ECL

Consensus Upside scenario allowance for ECL

Consensus Downside scenario allowance for ECL

Downside 2 scenario allowance for ECL

By geography at 31 December 2022

$m

$m

$m

$m

$m

$m

UK

Mortgages

147,306 

204 

188 

183 

189 

399 

Credit cards

6,518 

455 

434 

396 

442 

719 

Other

7,486 

368 

333 

274 

383 

605 

Mexico

Mortgages

6,319 

152 

127 

102 

183 

270 

Credit cards

1,616 

198 

162 

97

233 

289 

Other

3,447 

438 

400 

318 

503 

618 

Hong Kong

Mortgages

100,107 

1

1

1

1

Credit cards

8,003 

261 

227 

180 

417 

648 

Other

5,899 

85

81

74

100 

123 

UAE

Mortgages

2,170 

37

37

36

38

38

Credit cards

441 

41

37

21

68

86

Other

718 

17

17

15

19

22

France

Mortgages

21,440 

51

50

50

51

52

Other

1,433 

54

53

52

55

59

US

Mortgages

13,489 

7

6

6

8

15

Credit cards

219 

26

25

23

27

36

Canada

Mortgages

25,163 

45

44

43

46

58

Credit cards

299 

10

9

8

11

11

Other

1,399 

16

14

13

17

36

Other geographies

Mortgages

56,383 

199 

190 

183 

205 

253 

Credit cards

3,871 

192 

176 

150 

219 

324 

Other

3,630 

115 

111 

107 

119 

159 

Total

417,356 

2,972 

2,722 

2,331 

3,334 

4,821 

1 Allowance for ECL sensitivities exclude portfolios utilising less complex modelling approaches.

2 Classified as 'assets held for sale' at 31 December 2023.

3 Includes balances and allowance for ECL, which have been reclassified from 'loans and advances to customers' to 'assets held for sale' in the balance sheet at 31 December 2023. This also includes any balances and allowance for ECL, which continue to be reported as personal lending in 'loans and advances to customers' that are in accordance with the basis of inclusion for retail sensitivity analysis.

At 31 December 2023, the most significant level of allowance for ECL sensitivity was observed in the UK, Mexico and Hong Kong. Mortgages reflected the lowest level of allowance for ECL sensitivity across most markets given the significant levels of collateral relative to the exposure values. Credit cards and other unsecured lending across stage 1 and 2 are more sensitive to economic forecasts and therefore reflected the highest level of allowance for ECL sensitivity during 2023.

There is limited sensitivity in credit cards and other unsecured lending in stage 3 as levels of loss on defaulted exposures remain consistent through various economic conditions. The alternative downside is from the tail of the economic distribution where allowance for ECL is more sensitive based on historical experience.

 

The reported gross carrying amount by stage is representative of the weighted scenario allowance for ECL. The allowance for ECL sensitivity to the other scenarios includes changes in allowance for ECL due to the levels of loss and the migration of additional lending balances in or out of stage 2. Group ECL sensitivity results

The allowance for ECL of the scenarios and management judgemental adjustments is highly sensitive to movements in economic forecasts. Based upon the sensitivity tables presented above, if the Group allowance for ECL balance was estimated solely on the basis of the Central scenario, Downside scenario or the Downside 2 scenario at 31 December 2023, it would increase/(decrease) as presented in the below table.

Retail1

Wholesale1

Total Group ECL at 31 December 2023

$bn

$bn

Reported allowance for ECL

3.0 

2.5 

Scenarios

100% Consensus Central scenario

(0.1)

(0.2)

100% Consensus Upside scenario

(0.5)

(0.7)

100% Consensus Downside scenario

0.4 

0.8 

100% Downside 2 scenario

2.1 

4.5 

 

Total Group ECL at 31 December 2022

Reported allowance for ECL

3.0 

3.1 

Scenarios

100% Consensus Central scenario

(0.2)

(0.5)

100% Consensus Upside scenario

(0.6)

(1.1)

100% Consensus Downside scenario

0.4 

0.8 

100% Downside 2 scenario

1.8 

5.5 

1 On the same basis as retail and wholesale sensitivity analysis.

At 31 December 2023, the Group allowance for ECL remained unchanged in the retail portfolio and decreased by $0.6bn in the wholesale portfolio, compared with 31 December 2022.

The decrease in the Downside 2 scenario sensitivity within the wholesale portfolio since 31 December 2022 has been mostly driven by the crystallisation of defaults of higher risk exposures to the mainland China real estate sector and a reduction of related uncertainty. Within the retail portfolio, the increase in the Downside 2 scenario sensitivity was due to portfolio growth in Mexico and scenario forecast deterioration in Hong Kong.

At 31 December 2023, the sensitivity of the allowance for ECL to the consensus Central and consensus Upside scenarios decreased for both retail and wholesale portfolios due to lower macroeconomic forecast uncertainty, and the return to standardised weighting for the probability-weighted reported allowance.

 

Reconciliation from reported exposure and ECL to sensitised exposure and weighted ECL

Wholesale

Retail

Total

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/nominal amount

Allowance for ECL

Gross carrying/nominal amount

Allowance for ECL

$m

$m

$m

$m

$m

$m

Included in sensitivity analysis

1,990,378

(2,507)

442,373 

(2,962)

2,432,751

(5,469)

- Exclusions from sensitivity as described in the section above1

17,024 

(6,237)

308,569 

(93)

325,593 

(6,330)

- Debt instruments measured at fair value through other comprehensive income2

(302,348)

97 

(302,348)

97 

- Performance guarantees2

(93,312)

35 

(93,312)

35 

- Other financial assets at amortised cost not presented as wholesale or personal lending, including held for sale2

(579,534)

93 

(41,129)

174 

(620,663)

267 

- Other3

2,704 

(84)

(4,175)

(11)

(1,471)

(95)

As reported in the Summary of credit risk (excluding debt instruments measured at FVOCI) by stage distribution and ECL coverage by industry sector at 31 December 2023

1,034,912

(8,603)

705,638 

(2,892)

1,740,550

(11,495)

Other financial assets at amortised cost

960,271 

(422)

Total reported in the Summary of credit risk (excluding debt instruments measured at FVOCI) by stage distribution and ECL coverage by industry sector at 31 December 2023

2,700,821

(11,917)

1 Comprises wholesale defaulted obligors, retail portfolios utilising less complex modelling approaches, private banking and insurance.

2 The sensitivity analysis includes certain items reported in Other assets at amortised cost, which are not allocated to an industry in the credit tables. It also includes FVOCI and performance guarantees, which are presented separately in the credit tables.

3 Includes FX and other operational variances.

Reconciliations of changes in gross carrying/nominal amount and allowances for loans and advances to banks and customers including loan commitments and financial guarantees

The following disclosure provides a reconciliation by stage of the Group's gross carrying/nominal amount and allowances for loans and advances to banks and customers, including loan commitments and financial guarantees.

In addition, a reconciliation by stage of the Group's gross carrying amount and allowances for loans and advances to banks and customers and a reconciliation by stage of the Group's nominal amount and allowances for loan commitments and financial guarantees were included in this section following the adoption of the recommendations of the DECL Taskforce's third report.

Movements are calculated on a quarterly basis and therefore fully capture stage movements between quarters. If movements were calculated on a year-to-date basis they would only reflect the opening and closing position of the financial instrument.

The transfers of financial instruments represents the impact of stage transfers upon the gross carrying/nominal amount and associated allowance for ECL.

The net remeasurement of ECL arising from transfer of stage represents the increase or decrease due to these transfers, for example, moving from a 12-month (stage 1) to a lifetime (stage 2) ECL measurement basis. Net remeasurement excludes the underlying customer risk rating ('CRR')/probability of default ('PD') movements of the financial instruments transferring stage. This is captured, along with other credit quality movements in the 'changes to risk parameters - credit quality' line item.

Changes in 'Net new and further lending/repayments' represents the impact from volume movements within the Group's lending portfolio and includes 'New financial assets originated or purchased', 'assets derecognised (including final repayments)' and 'changes to risk parameters - further lending/repayment'.

Reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to banks and customers including

loan commitments and financial guarantees

(Audited)

Non-credit impaired

Credit impaired

Stage 1

Stage 2

Stage 3

POCI

Total

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

At 1 Jan 2023

1,433,643

(1,257)

177,223 

(3,710)

21,207 

(6,949)

129 

(38)

1,632,202

(11,954)

Transfers of financial instruments:

(18,948)

(1,048)

10,286 

2,228 

8,662 

(1,180)

transfers from stage 1 to stage 2

(150,728)

442 

150,728 

(442)

-

-

- transfers from stage 2 to

stage 1

133,079 

(1,467)

(133,079)

1,467 

- transfers to stage 3

(1,986)

23 

(8,600)

1,379 

10,586 

(1,402)

- transfers from stage 3

687 

(46)

1,237 

(176)

(1,924)

222 

-

Net remeasurement of ECL arising from transfer of stage

917 

(973)

(124)

(180)

Net new and further lending/repayments

77,693 

(185)

(36,795)

661 

(4,956)

1,117 

(36)

35,906 

1,596 

Changes to risk parameters - credit quality

307 

(1,262)

(3,896)

21 

(4,830)

Changes to models used for ECL calculation

(22)

46 

31 

Assets written off

(3,922)

3,922 

-

(3,922)

3,922 

Credit-related modifications that resulted in derecognition

(119)

95 

(119)

95 

Foreign exchange and others1

4,417 

(12)

2,370 

(92)

(73)

(55)

(8)

(16)

6,706 

(175)

At 31 Dec 2023

1,496,805

(1,300)

153,084 

(3,102)

20,799 

(7,063)

85 

(30)

1,670,773

(11,495)

ECL income statement change for the period

1,017 

(1,528)

(2,896)

24 

(3,383)

Recoveries

268 

Others

(195)

Total ECL income statement change for the period

(3,310)

1 Total includes $7.7bn of gross carrying loans and advances to customers and banks, which were classified to assets held for sale, and a corresponding allowance for ECL of $70m, reflecting business disposals as disclosed in Note 23 'Assets held for sale and liabilities of disposal groups held for sale' on page 401.

 

At 31 Dec 2023

12 months ended

31 Dec 2023

Gross carrying/nominal amount

Allowance for ECL

ECL charge

$m

$m

$m

As above

1,670,773

(11,495)

(3,310)

Other financial assets measured at amortised cost

960,271 

(422)

(35)

Non-trading reverse purchase agreement commitments

69,777 

Performance and other guarantees not considered for IFRS 9

(44)

Summary of financial instruments to which the impairment requirements in IFRS 9 are applied/Summary consolidated income statement

2,700,821

(11,917)

(3,389)

Debt instruments measured at FVOCI

302,348 

(97)

(58)

Total allowance for ECL/total income statement ECL change for the period

n/a

(12,014)

(3,447)

As shown in the previous table, the allowance for ECL for loans and advances to customers and banks and relevant loan commitments and financial guarantees decreased $459m during the period from $11,954m at 31 December 2022 to $11,495m at 31 December 2023.

This decrease was driven by:

- $3,922m of assets written off;

- $1,596m relating to volume movements, which included the allowance for ECL associated with new originations, assets derecognised and further lending/repayment;

- $95m relating to credit-related modifications, which resulted in derecognition; and

- $31m of changes to models used for ECL calculation.

These were partly offset by:

- $4,830m relating to underlying credit quality changes, including the credit quality impact of financial instruments transferring between stages;

- $180m relating to the net remeasurement impact of stage transfers; and

- foreign exchange and other movements of $175m.

 

The ECL charge for the period of $3,383m presented in the previous table consisted of $4,830m relating to underlying credit quality changes, including the credit quality impact of financial instruments transferring between stages and $180m relating to the net remeasurement impact of stage transfers.

This was partly offset by $1,596m relating to underlying net book volume movement and $31m in changes to models used for ECL calculation.

Summary views of the movement in wholesale and personal lending are presented on pages 179 and 192.

Reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to banks and customers including

loan commitments and financial guarantees

(Audited)

Non-credit impaired

Credit impaired

Stage 1

Stage 2

Stage 3

POCI

Total

Gross exposure

Allowance/ provision for ECL

Gross exposure

Allowance/ provision for ECL

Gross exposure

Allowance/ provision for ECL

Gross exposure

Allowance/ provision for ECL

Gross exposure

Allowance/ provision for ECL

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

At 1 Jan 2022

1,575,808 

(1,552)

155,654 

(3,323)

19,796 

(6,928)

275 

(64)

1,751,533 

(11,867)

Transfers of financial instruments:

(98,940)

(794)

88,974 

1,616 

9,966 

(822)

- transfers from stage 1 to

stage 2

(225,458)

469 

225,458 

(469)

- transfers from stage 2 to

stage 1

128,170 

(1,211)

(128,170)

1,211 

- transfers to stage 3

(2,392)

9

(10,083)

1,132 

12,475 

(1,141)

- transfers from stage 3

740 

(61)

1,769 

(258)

(2,509)

319 

Net remeasurement of ECL arising from transfer of stage

735 

(948)

(148)

(361)

Net new and further lending/repayments

99,253 

(175)

(44,877)

435 

(3,399)

674 

(133)

3

50,844 

937 

Changes to risk parameters - credit quality

400 

(1,671)

(3,019)

32

(4,258)

Changes to models used for ECL calculation

4

(151)

13

(134)

Assets written off

(2,791)

2,791 

(10)

10

(2,801)

2,801 

Credit-related modifications that resulted in derecognition

(32)

9

(32)

9

Foreign exchange and others1

(142,478)

125 

(22,528)

332 

(2,333)

481 

(3)

(19)

(167,342)

919 

At 31 Dec 2022

1,433,643 

(1,257)

177,223 

(3,710)

21,207 

(6,949)

129 

(38)

1,632,202 

(11,954)

ECL income statement change for the period

964 

(2,335)

0

(2,480)

35

(3,816)

Recoveries

316 

Others

(28)

Total ECL income statement change for the period

(3,528)

1 Total includes $82.7bn of gross carrying loans and advances to customers and banks, which were classified to assets held for sale, and a corresponding allowance for ECL of $426m, reflecting business disposals as disclosed in Note 23 'Assets held for sale and liabilities of disposal groups held for sale' on page 401.

At 31 Dec 2022

12 months ended

31 Dec 2022

Gross carrying/nominal amount

Allowance for ECL

ECL charge

$m

$m

$m

As above

1,632,202 

(11,954)

(3,528)

Other financial assets measured at amortised cost

954,934 

(493)

(38)

Non-trading reverse purchase agreement commitments

44,921 

Performance and other guarantees not considered for IFRS 9

39

Summary of financial instruments to which the impairment requirements in IFRS 9 are applied/Summary consolidated income statement

2,632,057 

(12,447)

(3,527)

Debt instruments measured at FVOCI

265,147 

(126)

(57)

Total allowance for ECL/total income statement ECL change for the period

n/a

(12,573)

(3,584)

 

Reconciliation of changes in gross carrying amount and allowances for loans and advances to banks and customers

Non-credit impaired

Credit impaired

Stage 1

Stage 2

Stage 3

POCI

Total

Gross carrying amount

Allowance for ECL

Gross carrying amount

Allowance for ECL

Gross carrying amount

Allowance for ECL

Gross carrying amount

Allowance for ECL

Gross carrying amount

Allowance for ECL

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

At 1 Jan 2023

879,023 

(1,109)

140,816 

(3,518)

19,586 

(6,851)

129

(38)

1,039,554

(11,516)

Transfers of financial instruments:

(19,276)

(980)

11,250 

2,154 

8,026 

(1,174)

- transfers from stage 1 to stage 2

(108,758)

423

108,758 

(423)

-

- transfers from stage 2 to stage 1

90,655 

(1,382)

(90,655)

1,382 

-

- transfers to stage 3

(1,692)

22

(7,975)

1,367 

9,667 

(1,389)

-

- transfers from stage 3

519 

(43)

1,122 

(172)

(1,641)

215

-

Net remeasurement of ECL arising from transfer of stage

859

(934)

(118)

(193)

Net new and further lending/repayments

55,024 

(210)

(32,069)

685

(4,233)

1,026 

(40)

3

18,682 

1,504 

Changes to risk parameters - credit quality

311

(1,292)

(3,804)

21

(4,764)

Changes to models used for ECL calculation

(17)

28

7

18 

Assets written off

(3,922)

3,922 

(3,922)

3,922 

Credit-related modifications that resulted in derecognition

(119)

95

(119)

95 

Foreign exchange and others1

6,092 

6

2,310 

(90)

(63)

(55)

(8)

(16)

8,331 

(155)

At 31 Dec 2023

920,863 

(1,140)

122,307 

(2,967)

19,275 

(6,952)

81

(30)

1,062,526

(11,089)

ECL income statement change for the period

943

(1,513)

(2,889)

24

(3,435)

Recoveries

268 

Others

(203)

Total ECL income statement change for the period

(3,370)

1 Total includes $7.7bn of gross carrying loans and advances to customers and banks, which were classified to assets held for sale, and a corresponding allowance for ECL of $70m, reflecting business disposals as disclosed in Note 23 'Assets held for sale and liabilities of disposal groups held for sale' on page 401.

Reconciliation of changes in nominal amount and allowances for loan commitments and financial guarantees

Non-credit impaired

Credit impaired

Stage 1

Stage 2

Stage 3

POCI

Total

Nominal amount

Allowance for ECL

Nominal amount

Allowance for ECL

Nominal amount

Allowance for ECL

Nominal amount

Allowance for ECL

Nominal amount

Allowance for ECL

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

At 1 Jan 2023

554,620 

(148)

36,407 

(192)

1,621 

(98)

-

592,648 

(438)

Transfers of financial instruments:

328 

(68)

(964)

74 

636 

(6)

- transfers from stage 1 to

stage 2

(41,970)

19 

41,970 

(19)

-

-

- transfers from stage 2 to

stage 1

42,424 

(85)

(42,424)

85 

- transfers to stage 3

(294)

(625)

12 

919 

(13)

-

- transfers from stage 3

168 

(3)

115 

(4)

(283)

-

-

Net remeasurement of ECL arising from transfer of stage

58 

(39)

(6)

13 

Net new and further lending/repayments

22,669 

25 

(4,726)

(24)

(723)

91 

17,224 

92 

Changes to risk parameters - credit quality

(4)

30 

(92)

(66)

Changes to models used for ECL calculation

(5)

18 

13 

Foreign exchange and others

(1,675)

(18)

60 

(2)

(10)

(1,625)

(20)

At 31 Dec 2023

575,942 

(160)

30,777 

(135)

1,524 

(111)

-

608,247 

(406)

ECL income statement change for the period

74 

(15)

(7)

52 

Recoveries

Others

Total ECL income statement change for the period

60 

 

Credit quality

Credit quality of financial instruments

(Audited)

We assess the credit quality of all financial instruments that are subject to credit risk. The credit quality of financial instruments is a point-in-time assessment of PD, whereas stages 1 and 2 are determined based on relative deterioration of credit quality since initial recognition for the majority of portfolios. Accordingly, for non-credit-impaired financial instruments, there is no direct relationship

between the credit quality assessment and stages 1 and 2, although

typically the lower credit quality bands exhibit a higher proportion in stage 2.

The five credit quality classifications provided below each encompass a range of granular internal credit rating grades assigned to wholesale and personal lending businesses and the external ratings attributed by external agencies to debt securities, as shown in the table on page 148.

Distribution of financial instruments by credit quality at 31 December 2023

(Audited)

Gross carrying/notional amount

Allowance for ECL/other credit provisions

Net

Strong

Good

Satisfactory

Sub-standard

Credit impaired

Total

$m

$m

$m

$m

$m

$m

$m

$m

In-scope for IFRS 9 ECL

Loans and advances to customers held at amortised cost

497,665 

206,476 

197,582 

28,532 

19,354 

949,609 

(11,074)

938,535 

- personal

346,562 

62,656 

32,314 

2,485 

3,505 

447,522 

(2,867)

444,655 

- corporate and commercial

118,123 

123,713 

145,249 

25,531 

15,039 

427,655 

(7,803)

419,852 

- non-bank financial institutions

32,980 

20,107 

20,019 

516 

810 

74,432 

(404)

74,028 

Loans and advances to banks held at amortised cost

101,057 

4,640 

6,363 

855 

112,917 

(15)

112,902 

Cash and balances at central banks

284,723 

1,068 

77 

285,868 

-

285,868 

Items in the course of collection from other banks

6,327 

15 

6,342 

6,342 

Hong Kong Government certificates of indebtedness

42,024 

42,024 

42,024 

Reverse repurchase agreements - non-trading

170,494 

46,884 

34,206 

633 

252,217 

252,217 

Financial investments

143,333 

3,814 

1,137 

62 

148,346 

(20)

148,326 

Assets held for sale

68,501 

16,403 

14,812 

2,939 

531 

103,186 

(324)

102,862 

Other assets

99,857 

11,967 

9,965 

366 

133 

122,288 

(78)

122,210 

- endorsements and acceptances

2,405 

2,666 

2,707 

161 

18 

7,957 

(18)

7,939 

- accrued income and other

97,452 

9,301 

7,258 

205 

115 

114,331 

(60)

114,271 

Debt instruments measured at fair value through other comprehensive income1

288,959 

12,037 

7,897 

805 

309,703 

(97)

309,606 

Out-of-scope for IFRS 9 ECL

Trading assets

122,695 

20,595 

20,746 

1,326 

135 

165,497 

165,497 

Other financial assets designated and otherwise mandatorily measured at fair value through profit or loss

52,649 

11,517 

4,733 

84 

68,989 

68,989 

Derivatives

196,098 

27,377 

6,041 

187 

11 

229,714 

229,714 

Assets held for sale

12,495 

12,495 

12,495 

Total gross carrying amount on balance sheet

2,086,877

362,793 

303,559 

35,789 

20,177 

2,809,195

(11,608)

2,797,587

Percentage of total

credit quality (%)

74.3

12.9

10.8

1.3

0.7

100

Loan and other credit-related commitments

436,359 

142,500 

73,230 

7,782 

1,144 

661,015 

(367)

660,648 

Financial guarantees

7,700 

4,146 

4,080 

699 

384 

17,009 

(39)

16,970 

In-scope: Irrevocable loan commitments and financial guarantees

444,059 

146,646 

77,310 

8,481 

1,528 

678,024 

(406)

677,618 

Loan and other credit-related commitments

92,509 

77,891 

61,462 

3,896 

377 

236,135 

236,135 

Performance and other guarantees

39,784 

32,231 

19,445 

1,853 

964 

94,277 

(145)

94,132 

Out-of-scope: Revocable loan commitments and non-financial guarantees

132,293 

110,122 

80,907 

5,749 

1,341 

330,412 

(145)

330,267 

1 For the purposes of this disclosure, gross carrying amount is defined as the amortised cost of a financial asset before adjusting for any loss allowance. As such, the gross carrying amount of debt instruments at FVOCI as presented above will not reconcile to the balance sheet as it excludes fair value gains and losses.

Distribution of financial instruments by credit quality at 31 December 2022 (continued)

(Audited)

Gross carrying/notional amount

Allowance for ECL/other credit provisions

Net

Strong

Good

Satisfactory

Sub- standard

Credit impaired

Total

$m

$m

$m

$m

$m

$m

$m

$m

In-scope for IFRS 9 ECL

Loans and advances to customers held at amortised cost

492,711 

196,735 

196,486 

29,443 

19,633 

935,008 

(11,447)

923,561 

- personal

333,839 

45,590 

28,918 

3,196 

3,339 

414,882 

(2,870)

412,012 

- corporate and commercial

126,521 

132,128 

153,841 

24,887 

15,825 

453,202 

(8,320)

444,882 

- non-bank financial institutions

32,351 

19,017 

13,727 

1,360 

469 

66,924 

(257)

66,667 

Loans and advances to banks held at amortised cost

92,675 

4,833 

5,643 

1,311 

82

104,544 

(69)

104,475 

Cash and balances at central banks

325,119 

1,296 

590 

327,005 

(3)

327,002 

Items in the course of collection from other banks

7,280 

12

5

7,297 

7,297 

Hong Kong Government certificates of indebtedness

43,787 

43,787 

43,787 

Reverse repurchase agreements - non-trading

170,386 

41,659 

41,686 

20

3

253,754 

253,754 

Financial investments

103,379 

3,212 

2,334 

161 

109,086 

(20)

109,066 

Assets held for sale

67,616 

17,993 

13,972 

2,333 

642 

102,556 

(415)

102,141 

Other assets

91,006 

11,126 

8,875 

290 

152 

111,449 

(55)

111,394 

- endorsements and acceptances

2,350 

3,059 

2,815 

175 

25

8,424 

(17)

8,407 

- accrued income and other

88,656 

8,067 

6,060 

115 

127 

103,025 

(38)

102,987 

Debt instruments measured at fair value through other comprehensive income1

260,654 

9,957 

5,730 

1,910 

7

278,258 

(126)

278,132 

Out-of-scope for IFRS 9 ECL

Trading assets

91,330 

14,371 

23,414 

820 

133 

130,068 

130,068 

Other financial assets designated and otherwise mandatorily measured at fair value through profit or loss

49,602 

11,116 

3,145 

187 

64,050 

64,050 

Derivatives

241,918 

34,181 

7,843 

181 

36

284,159 

284,159 

Assets held for sale

15,254 

15,254 

15,254 

Total gross carrying amount on balance sheet

2,052,717 

346,491 

309,723 

36,656 

20,688 

2,766,275 

(12,135)

2,754,140 

Percentage of total

credit quality (%)

74.2

12.6

11.2

1.3

0.7

100

-

-

Loan and other credit-related commitments

402,972 

132,402 

74,410 

7,632 

1,372 

618,788 

(386)

618,402 

Financial guarantees

8,281 

4,669 

4,571 

1,013 

249 

18,783 

(52)

18,731 

In-scope: Irrevocable loan commitments and financial guarantees

411,253 

137,071 

78,981 

8,645 

1,621 

637,571 

(438)

637,133 

Loan and other credit-related commitments

76,098 

69,667 

59,452 

3,360 

489 

209,066 

209,066 

Performance and other guarantees

37,943 

30,029 

17,732 

2,137 

399 

88,240 

(110)

88,130 

Out-of-scope: Revocable loan commitments and non-financial guarantees

114,041 

99,696 

77,184 

5,497 

888 

297,306 

(110)

297,196 

1 For the purposes of this disclosure, gross carrying amount is defined as the amortised cost of a financial asset before adjusting for any loss allowance. As such, the gross carrying amount of debt instruments at FVOCI as presented above will not reconcile to the balance sheet as it excludes fair value gains and losses.

 

Distribution of financial instruments to which the impairment requirements in IFRS 9 are applied, by credit quality and stage allocation

(Audited)

Gross carrying/notional amount

Allowance for ECL

Net

Strong

Good

Satisfactory

Sub-standard

Credit impaired

Total

$m

$m

$m

$m

$m

$m

$m

$m

Loans and advances to customers at amortised cost

497,665 

206,476 

197,582 

28,532 

19,354 

949,609 

(11,074)

938,535 

- stage 1

478,422 

177,410 

147,940 

5,612 

809,384 

(1,130)

808,254 

- stage 2

19,243 

29,066 

49,642 

22,920 

120,871 

(2,964)

117,907 

- stage 3

19,273 

19,273 

(6,950)

12,323 

- POCI

81 

81 

(30)

51 

Loans and advances to banks at amortised cost

101,057 

4,640 

6,363 

855 

112,917 

(15)

112,902 

- stage 1

101,011 

4,631 

5,550 

287 

111,479 

(10)

111,469 

- stage 2

46 

813 

568 

1,436 

(3)

1,433 

- stage 3

(2)

- POCI

Other financial assets measured at amortised cost

815,259 

80,151 

60,197 

4,000 

664 

960,271 

(422)

959,849 

- stage 1

814,776 

78,486 

53,095 

516 

946,873 

(109)

946,764 

- stage 2

483 

1,665 

7,102 

3,484 

12,734 

(132)

12,602 

- stage 3

664 

664 

(181)

483 

- POCI

Loan and other credit-related commitments

436,359 

142,500 

73,230 

7,782 

1,144 

661,015 

(367)

660,648 

- stage 1

432,017 

135,192 

61,213 

2,527 

630,949 

(153)

630,796 

- stage 2

4,342 

7,308 

12,017 

5,255 

28,922 

(128)

28,794 

- stage 3

1,140 

1,140 

(86)

1,054 

- POCI

Financial guarantees

7,700 

4,146 

4,080 

699 

384 

17,009 

(39)

16,970 

- stage 1

7,497 

3,943 

3,204 

102 

14,746 

(7)

14,739 

- stage 2

203 

203 

876 

597 

1,879 

(7)

1,872 

- stage 3

384 

384 

(25)

359 

- POCI

At 31 Dec 2023

1,858,040

437,913 

341,452 

41,868 

21,548 

2,700,821

(11,917)

2,688,904

Debt instruments at FVOCI1

- stage 1

288,909 

12,037 

7,579 

308,525 

(37)

308,488 

- stage 2

50 

318 

805 

1,173 

(59)

1,114 

- stage 3

(1)

- POCI

At 31 Dec 2023

288,959 

12,037 

7,897 

805 

309,703 

(97)

309,606 

 

Loans and advances to customers at amortised cost

492,711 

196,735 

196,486 

29,443 

19,633 

935,008 

(11,447)

923,561 

- stage 1

458,706 

170,055 

142,408 

5,130 

776,299 

(1,092)

775,207 

- stage 2

34,005 

26,680 

54,078 

24,313 

139,076 

(3,488)

135,588 

- stage 3

19,504 

19,504 

(6,829)

12,675 

- POCI

129 

129 

(38)

91

Loans and advances to banks at amortised cost

92,675 

4,833 

5,643 

1,311 

82

104,544 

(69)

104,475 

- stage 1

92,377 

4,465 

5,466 

415 

102,723 

(18)

102,705 

- stage 2

298 

368 

177 

896 

1,739 

(29)

1,710 

- stage 3

82

82

(22)

60

- POCI

Other financial assets measured at amortised cost

808,573 

75,298 

67,462 

2,804 

797 

954,934 

(493)

954,441 

- stage 1

807,893 

70,794 

59,887 

224 

938,798 

(95)

938,703 

- stage 2

680 

4,504 

7,575 

2,580 

15,339 

(165)

15,174 

- stage 3

797 

797 

(233)

564 

- POCI

Loan and other credit-related commitments

402,972 

132,402 

74,410 

7,632 

1,372 

618,788 

(386)

618,402 

- stage 1

398,120 

121,581 

60,990 

2,692 

583,383 

(141)

583,242 

- stage 2

4,852 

10,821 

13,420 

4,940 

34,033 

(180)

33,853 

- stage 3

1,372 

1,372 

(65)

1,307 

- POCI

Financial guarantees

8,281 

4,669 

4,571 

1,013 

249 

18,783 

(52)

18,731 

- stage 1

8,189 

4,245 

3,488 

149 

16,071 

(6)

16,065 

- stage 2

92

424 

1,083 

864 

2,463 

(13)

2,450 

- stage 3

249 

249 

(33)

216 

- POCI

At 31 Dec 2022

1,805,212 

413,937 

348,572 

42,203 

22,133 

2,632,057 

(12,447)

2,619,610 

Debt instruments at FVOCI1

- stage 1

260,411 

9,852 

5,446 

275,709 

(67)

275,642 

- stage 2

243 

105 

284 

1,910 

2,542 

(58)

2,484 

- stage 3

5

5

(1)

4

- POCI

2

2

2

At 31 Dec 2022

260,654 

9,957 

5,730 

1,910 

7

278,258 

(126)

278,132 

1 For the purposes of this disclosure, gross carrying amount is defined as the amortised cost of a financial asset before adjusting for any loss allowance. As such, the gross carrying amount of debt instruments at FVOCI as presented above will not reconcile to the balance sheet as it excludes fair value gains and losses.

Credit-impaired loans

(Audited)

We determine that a financial instrument is credit impaired and in stage 3 by considering relevant objective evidence, primarily whether:

- contractual payments of either principal or interest are past due for more than 90 days;

- there are other indications that the borrower is unlikely to pay, such as when a concession has been granted to the borrower for economic or legal reasons relating to the borrower's financial condition; and

- the loan is otherwise considered to be in default. If such unlikeliness to pay is not identified at an earlier stage, it is deemed

 

to occur when an exposure is 90 days past due. Therefore, the definitions of credit impaired and default are aligned as far as possible so that stage 3 represents all loans that are considered defaulted or otherwise credit impaired.

Forbearance

The following table shows the gross carrying amounts and allowances for ECL of the Group's holdings of forborne loans and advances to customers by industry sector and by stages.

A summary of our current policies and practices for forbearance is set out in 'Credit risk management' on page 147.

Forborne loans and advances to customers at amortised cost by stage allocation

Performing forborne

Non-performing forborne

Total forborne

Stage 2

Stage 3

POCI

Total

$m

$m

$m

$m

Gross carrying amount

Personal

816 

1,282 

2,098 

- first lien residential mortgages

530 

815 

1,345 

- second lien residential mortgages

- guaranteed loans in respect of residential property

24 

20 

44 

- other personal lending which is secured

- credit cards

96 

83 

179 

- other personal lending which is unsecured

155 

349 

504 

- motor vehicle finance

10 

Wholesale

5,848 

5,505 

68 

11,421 

- corporate and commercial

5,778 

5,459 

68 

11,305 

- non-bank financial institutions

70 

46 

116 

At 31 Dec 2023

6,664 

6,787 

68 

13,519 

Allowance for ECL

Personal

(113)

(307)

(420)

- first lien residential mortgages

(50)

(113)

(163)

- second lien residential mortgages

(3)

(3)

- guaranteed loans in respect of residential property

(2)

(2)

- other personal lending which is secured

(1)

(1)

- credit cards

(17)

(46)

(63)

- other personal lending which is unsecured

(43)

(142)

(185)

- motor vehicle finance

(3)

(3)

Wholesale

(259)

(1,932)

(28)

(2,219)

- corporate and commercial

(257)

(1,920)

(28)

(2,205)

- non-bank financial institutions

(2)

(12)

(14)

At 31 Dec 2023

(372)

(2,239)

(28)

(2,639)

 

Gross carrying amount

Personal

651 

1,171 

1,822 

- first lien residential mortgages

369 

738 

1,107 

- second lien residential mortgages

7

7

- guaranteed loans in respect of residential property

4

4

- other personal lending which is secured

5

13

18

- credit cards

93

75

168 

- other personal lending which is unsecured

179 

334 

513 

- motor vehicle finance

5

5

Wholesale

4,873 

4,576 

107 

9,556 

- corporate and commercial

4,859 

4,562 

107 

9,528 

- non-bank financial institutions

14

14

28

At 31 Dec 2022

5,524 

5,747 

107 

11,378 

Allowance for ECL

Personal

(124)

(302)

(426)

- first lien residential mortgages

(49)

(118)

(167)

- second lien residential mortgages

(3)

(3)

- guaranteed loans in respect of residential property

(3)

(3)

- other personal lending which is secured

(2)

(2)

- credit cards

(19)

(44)

(63)

- other personal lending which is unsecured

(54)

(132)

(186)

- motor vehicle finance

(2)

(2)

Wholesale

(152)

(1,497)

(25)

(1,674)

- corporate and commercial

(151)

(1,490)

(25)

(1,666)

- non-bank financial institutions

(1)

(7)

(8)

At 31 Dec 2022

(276)

(1,799)

(25)

(2,100)

 

 

Forborne loans and advances to customers by legal entities

HSBC UK Bank plc

HSBC Bank plc

The Hongkong and Shanghai Banking Corporation Limited

 HSBC Bank Middle East Limited

 HSBC North America Holdings Inc.

 Grupo Financiero HSBC, S.A. de C.V.

Other trading entities

Total

$m

$m

$m

$m

$m

$m

$m

$m

Gross carrying amount

Performing forborne

1,478 

2,081 

1,574 

31 

954 

503 

43 

6,664 

Non-performing forborne

1,936 

1,199 

2,250 

471 

430 

233 

336 

6,855 

At 31 Dec 2023

3,414 

3,280 

3,824 

502 

1,384 

736 

379 

13,519 

Allowance for ECL

Performing forborne

(75)

(25)

(142)

(1)

(43)

(84)

(2)

(372)

Non-performing forborne

(289)

(400)

(986)

(225)

(74)

(126)

(167)

(2,267)

At 31 Dec 2023

(364)

(425)

(1,128)

(226)

(117)

(210)

(169)

(2,639)

Gross carrying amount

Performing forborne

899 

2,222 

276 

435 

997 

530 

165 

5,524 

Non-performing forborne

1,723 

913 

1,562 

554 

209 

195 

698 

5,854 

At 31 Dec 2022

2,622 

3,135 

1,838 

989 

1,206 

725 

863 

11,378 

Allowance for ECL

Performing forborne

(63)

(31)

(21)

(7)

(50)

(79)

(25)

(276)

Non-performing forborne

(257)

(310)

(525)

(356)

(21)

(111)

(244)

(1,824)

At 31 Dec 2022

(320)

(341)

(546)

(363)

(71)

(190)

(269)

(2,100)

 

Wholesale lending

This section provides further details on the major legal entities, countries, territories and products comprising wholesale loans and advances to customers and banks. Product granularity is also provided by stage with legal entity data presented for loans and advances to customers, banks, other credit commitments, financial guarantees and similar contracts. Additionally, this section provides a reconciliation of the opening 1 January 2023 to 31 December 2023 closing gross carrying/nominal amounts and the associated allowance for ECL.

At 31 December 2023, wholesale lending for loans and advances to banks and customers of $615bn decreased by $9.6bn compared with 31 December 2022. This included favourable foreign exchange movements of $6.1bn. Excluding foreign exchange movements, the total loans and advances to customers decrease of $24.6bn was driven by a $31.5bn decrease in corporate and commercial balances, partly offset by a $6.9bn increase in balances from non-bank financial institutions. In addition, there was a $8.9bn increase in loans and advances to banks.

The underlying reduction in corporate and commercial lending was mainly driven by decreases in Hong Kong (down $18.6bn), in the UK (down $5.4bn), in mainland China (down $2.2bn), in France (down $1.6bn), in the US (down $1.3bn). These were partly offset by increased lending in India (up $1.8bn). There was a $2.1bn decrease from the merger of our business in Oman.

The underlying decrease in loans advances to corporate and commercial customers within stage 2 included repayments within our commercial real estate portfolio in Hong Kong, together with de-risking measures in our mainland China commercial real estate portfolio. In addition, there was a further decrease in the wholesale and retail trade portfolio in the UK largely from repayments and improvements in the economic outlook that led to upgrades to stage 1.

The underlying growth in loans and advances to non-bank financial institutions was mainly driven by the formation of HSBC Innovation Banking, following the acquisition of SVB UK, in the UK (up $6.4bn). In addition, increases in France (up $1.4bn) were partly offset by decreases in mainland China (down $0.9bn).

 

The underlying growth in loans and advances to banks was mainly driven by central bank balances and money market lending growth in Singapore (up $6.5bn), Hong Kong (up $5.1bn), the UK (up $2.8bn) and Egypt (up $1.5bn). These were partly offset by reductions in mainland China (down $2.6bn), Malaysia (down $1.6bn), Switzerland (down $1.4bn) and the UAE (down $1.2bn). There was also a $0.6bn decrease from the merger of our business in Oman.

Loan commitments and financial guarantees increased by $27.5bn since 31 December 2022 to $419.9bn at 31 December 2023. Excluding favourable foreign exchange movements of $8.7bn, loan commitments and financial guarantees grew by $18.8bn. This can be mainly attributed to a $23.2bn increase in unsettled reverse repurchase agreements, partly offset by a decrease of $6.3bn in loan commitments with corporate and commercial customers.

The allowance for ECL attributable to loans and advances to banks and customers of $8.2bn at 31 December 2023 decreased from $8.6bn at 31 December 2022. This included adverse foreign exchange movements of $0.1bn.

Excluding foreign exchange movements, the total decrease in the wholesale allowance for ECL attributable to loans and advances to customers and banks was mostly driven by a $0.6bn decrease in corporate and commercial balances, partly offset by a $0.1bn increase in loans to non-bank financial institutions and banks.

The allowance for ECL attributable to loan commitments and financial guarantees at 31 December 2023 remained stable at $0.4bn compared with 31 December 2022.

The table below provides a breakdown by industry sector and stage of the Group's gross carrying amount and allowances for ECL for wholesale loans and advances to banks and customers. Counterparties or exposures are classified when presenting comparable economic characteristics, or engaged in similar activities so that their collective ability to meet contractual obligations is uniformly affected by changes in economic, political or other conditions. Therefore, the industry classification does not adhere to Nomenclature des Activités Économiques dans la Communauté Européenne ('NACE'), which is applicable to other financial regulatory reporting.

Total wholesale lending for loans and advances to banks and customers by stage distribution

Gross carrying amount

Allowance for ECL

Stage 1

Stage 2

Stage 3

POCI

Total

Stage 1

Stage 2

Stage 3

POCI

Total

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

Corporate and commercial

342,878 

69,738 

14,958 

81 

427,655 

(499)

(1,500)

(5,774)

(30)

(7,803)

- agriculture, forestry and fishing

5,207 

1,662 

312 

7,181 

(13)

(53)

(64)

(130)

- mining and quarrying

6,260 

638 

325 

7,223 

(7)

(11)

(83)

(101)

- manufacturing

69,690 

13,744 

1,877 

22 

85,333 

(89)

(194)

(839)

(21)

(1,143)

- electricity, gas, steam and air-conditioning supply

12,817 

1,283 

255 

14,355 

(14)

(17)

(88)

(119)

- water supply, sewerage, waste management and remediation

2,753 

407 

102 

3,262 

(5)

(7)

(51)

(63)

- real estate and construction

73,701 

21,871 

5,835 

48 

101,455 

(96)

(629)

(2,554)

(7)

(3,286)

- of which: commercial real estate

59,883 

19,107 

4,552 

47 

83,589 

(73)

(603)

(2,091)

(7)

(2,774)

- wholesale and retail trade, repair of motor vehicles and motorcycles

66,083 

10,676 

2,358 

79,121 

(80)

(127)

(1,132)

(2)

(1,341)

- transportation and storage

17,117 

3,894 

445 

21,456 

(18)

(52)

(160)

(230)

- accommodation and food

9,681 

5,135 

1,058 

15,874 

(27)

(118)

(112)

(257)

- publishing, audiovisual and broadcasting

17,455 

2,066 

210 

19,731 

(42)

(81)

(50)

(173)

- professional, scientific and technical activities

22,686 

3,327 

733 

26,753 

(32)

(63)

(306)

(401)

- administrative and support services

19,055 

2,551 

597 

22,203 

(31)

(63)

(174)

(268)

- public administration and defence, compulsory social security

1,037 

1,042 

- education

1,137 

277 

46 

1,460 

(3)

(8)

(4)

(15)

- health and care

3,245 

808 

183 

4,236 

(9)

(21)

(26)

(56)

- arts, entertainment and recreation

1,666 

196 

99 

1,961 

(5)

(6)

(31)

(42)

- other services

7,065 

972 

318 

8,355 

(26)

(37)

(90)

(153)

- activities of households

684 

10 

694 

- extra-territorial organisations and bodies activities

100 

101 

- government

5,420 

202 

205 

5,827 

(2)

(10)

(12)

- asset-backed securities

19 

13 

32 

(13)

(13)

Non-bank financial institutions

69,972 

3,650 

810 

74,432 

(52)

(30)

(322)

(404)

Loans and advances to banks

111,479 

1,436 

112,917 

(10)

(3)

(2)

(15)

At 31 Dec 2023

524,329 

74,824 

15,770 

81 

615,004 

(561)

(1,533)

(6,098)

(30)

(8,222)

By legal entity

HSBC UK Bank plc

76,793 

18,735 

3,769 

99,297 

(213)

(474)

(593)

(1,280)

HSBC Bank plc

82,025 

8,452 

2,673 

40 

93,190 

(69)

(138)

(1,035)

(7)

(1,249)

The Hongkong and Shanghai Banking Corporation Limited

287,876 

37,402 

7,077 

38 

332,393 

(185)

(696)

(3,349)

(21)

(4,251)

HSBC Bank Middle East Limited

21,927 

1,598 

894 

24,422 

(17)

(11)

(571)

(2)

(601)

HSBC North America Holdings Inc.

30,797 

5,712 

583 

37,092 

(24)

(145)

(127)

(296)

Grupo Financiero HSBC, S.A. de C.V.

13,714 

1,186 

382 

15,282 

(39)

(56)

(231)

(326)

Other trading entities

11,164 

1,739 

392 

13,295 

(14)

(13)

(192)

(219)

Holding companies, shared service centres and intra-Group eliminations

33 

33 

At 31 Dec 2023

524,329 

74,824 

15,770 

81 

615,004 

(561)

(1,533)

(6,098)

(30)

(8,222)

 

Total wholesale lending for loans and other credit-related commitments and financial guarantees to banks and customers by stage distribution1

Nominal amount

Allowance for ECL

Stage 1

Stage 2

Stage 3

POCI

Total

Stage 1

Stage 2

Stage 3

POCI

Total

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

Corporate and commercial

256,367 

22,218 

1,066 

279,655 

(126)

(125)

(107)

(358)

Financial

135,039 

5,111 

103 

140,253 

(11)

(10)

(2)

(23)

At 31 Dec 2023

391,406 

27,329 

1,169 

419,908 

(137)

(135)

(109)

(381)

By legal entity

HSBC UK Bank plc

31,982 

5,760 

350 

38,092 

(31)

(32)

(56)

(119)

HSBC Bank plc

148,980 

9,466 

310 

158,760 

(20)

(27)

(27)

(74)

The Hongkong and Shanghai Banking Corporation Limited

70,436 

3,975 

79 

74,490 

(59)

(39)

(16)

(114)

HSBC Bank Middle East Limited

6,944 

323 

56 

7,323 

(4)

(1)

(3)

(8)

HSBC North America Holdings Inc.

101,067 

5,103 

248 

106,418 

(14)

(27)

(1)

(42)

HSBC Bank Canada

28,156 

2,461 

66 

30,683 

(8)

(8)

(3)

(19)

Grupo Financiero HSBC, S.A. de C.V.

2,092 

34 

2,126 

(1)

(1)

Other trading entities

1,749 

207 

60 

2,016 

(1)

(3)

(4)

At 31 Dec 2023

391,406 

27,329 

1,169 

419,908 

(137)

(135)

(109)

(381)

1 Included in loans and other credit-related commitments and financial guarantees is $70bn relating to unsettled reverse repurchase agreements, which once drawn are classified as 'Reverse repurchase agreements - non-trading'.

Total wholesale lending for loans and advances to banks and customers by stage distribution (continued)

Gross carrying amount

Allowance for ECL

Stage 1

Stage 2

Stage 3

POCI

Total

Stage 1

Stage 2

Stage 3

POCI

Total

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

Corporate and commercial

351,885 

85,492 

15,696 

129 

453,202 

(488)

(1,907)

(5,887)

(38)

(8,320)

- agriculture, forestry and fishing

4,805 

1,505 

261 

6,571 

(10)

(44)

(68)

(122)

- mining and quarrying

6,424 

1,463 

232 

1

8,120 

(5)

(21)

(145)

(1)

(172)

- manufacturing

70,144 

15,251 

2,016 

49

87,460 

(93)

(164)

(867)

(29)

(1,153)

- electricity, gas, steam and air-conditioning supply

14,402 

1,799 

277 

16,478 

(10)

(31)

(67)

(108)

- water supply, sewerage, waste management and remediation

2,690 

277 

26

2,993 

(3)

(5)

(13)

(21)

- real estate and construction

81,830 

27,104 

5,625 

26

114,585 

(107)

(954)

(2,229)

(3)

(3,293)

- of which: commercial real estate

68,120 

23,608 

4,648 

19

96,395 

(82)

(865)

(1,799)

(2,746)

- wholesale and retail trade, repair of motor vehicles and motorcycles

63,752 

15,867 

2,805 

5

82,429 

(97)

(225)

(1,341)

(3)

(1,666)

- transportation and storage

19,068 

5,062 

556 

24,686 

(30)

(65)

(153)

(248)

- accommodation and food

9,862 

6,523 

787 

2

17,174 

(23)

(139)

(81)

(1)

(244)

- publishing, audiovisual and broadcasting

16,574 

1,537 

249 

28

18,388 

(22)

(36)

(58)

(1)

(117)

- professional, scientific and technical activities

15,164 

2,229 

542 

17,935 

(21)

(51)

(200)

(272)

- administrative and support services

20,592 

3,505 

962 

18

25,077 

(25)

(90)

(293)

(408)

- public administration and defence, compulsory social security

1,166 

14

1,180 

(1)

(1)

- education

1,325 

181 

87

1,593 

(4)

(5)

(22)

(31)

- health and care

2,993 

643 

266 

3,902 

(6)

(17)

(67)

(90)

- arts, entertainment and recreation

1,264 

452 

146 

1,862 

(4)

(16)

(57)

(77)

- other services

10,335 

1,547 

589 

12,471 

(25)

(30)

(219)

(274)

- activities of households

730 

14

744 

- extra-territorial organisations and bodies activities

47

47

- government

8,699 

506 

270 

9,475 

(3)

(7)

(10)

- asset-backed securities

19

13

32

(13)

(13)

Non-bank financial institutions

61,737 

4,718 

469 

66,924 

(43)

(77)

(137)

(257)

Loans and advances to banks

102,723 

1,739 

82

104,544 

(18)

(29)

(22)

(69)

At 31 Dec 2022

516,345 

91,949 

16,247 

129 

624,670 

(549)

(2,013)

(6,046)

(38)

(8,646)

By legal entity

HSBC UK Bank plc

64,930 

18,856 

4,439 

28

88,253 

(165)

(445)

(643)

(1)

(1,254)

HSBC Bank plc

83,174 

9,175 

2,631 

3

94,983 

(56)

(181)

(1,075)

(1,312)

The Hongkong and Shanghai Banking Corporation Limited

292,022 

50,708 

6,934 

80

349,744 

(216)

(1,074)

(3,125)

(24)

(4,439)

HSBC Bank Middle East Limited

21,922 

1,777 

946 

4

24,649 

(11)

(21)

(684)

(3)

(719)

HSBC North America Holdings Inc.

30,816 

6,861 

211 

37,888 

(24)

(194)

(22)

(240)

Grupo Financiero HSBC, S.A. de C.V.

9,969 

1,979 

399 

12,347 

(48)

(62)

(225)

(335)

Other trading entities

13,512 

2,593 

687 

14

16,806 

(29)

(36)

(272)

(10)

(347)

Holding companies, shared service centres and intra-Group eliminations

At 31 Dec 2022

516,345 

91,949 

16,247 

129 

624,670 

(549)

(2,013)

(6,046)

(38)

(8,646)

 

Total wholesale lending for loans and other credit-related commitments and financial guarantees by stage distribution1 (continued)

Nominal amount

Allowance for ECL

Stage 1

Stage 2

Stage 3

POCI

Total

Stage 1

Stage 2

Stage 3

POCI

Total

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

Corporate and commercial

252,860 

29,116 

798 

282,774 

(116)

(178)

(96)

(390)

Financial

105,950 

3,683 

23

109,656 

(5)

(14)

(2)

(21)

At 31 Dec 2022

358,810 

32,799 

821 

392,430 

(121)

(192)

(98)

(411)

By legal entity

HSBC UK Bank plc

26,036 

5,527 

208 

31,771 

(24)

(45)

(38)

(107)

HSBC Bank plc

142,100 

11,710 

291 

154,101 

(16)

(41)

(47)

(104)

The Hongkong and Shanghai Banking Corporation Limited

67,473 

6,081 

114 

73,668 

(54)

(53)

(9)

(116)

HSBC Bank Middle East Limited

6,683 

231 

14

6,928 

(2)

(2)

(4)

HSBC North America Holdings Inc.

88,039 

3,959 

87

92,085 

(13)

(32)

(2)

(47)

HSBC Bank Canada

24,395 

4,671 

84

29,150 

(8)

(15)

(23)

Grupo Financiero HSBC, S.A. de C.V.

2,468 

240 

3

2,711 

(1)

(1)

Other trading entities

1,616 

380 

20

2,016 

(3)

(4)

(2)

(9)

At 31 Dec 2022

358,810 

32,799 

821 

392,430 

(121)

(192)

(98)

(411)

1 Included in loans and other credit-related commitments and financial guarantees is $45bn relating to unsettled reverse repurchase agreements, which once drawn are classified as 'Reverse repurchase agreements - non-trading'.

Wholesale lending - reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to banks and

customers including loan commitments and financial guarantees

(Audited)

Non-credit impaired

Credit impaired

Stage 1

Stage 2

Stage 3

POCI

Total

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

At 1 Jan 2023

830,322 

(670)

124,660 

(2,205)

17,068 

(6,144)

129 

(38)

972,179 

(9,057)

Transfers of financial instruments:

(16,804)

(429)

10,247 

1,141 

6,557 

(712)

transfers from stage 1 to stage 2

(93,511)

172 

93,511 

(172)

-

transfers from stage 2 to stage 1

77,772 

(605)

(77,772)

605 

-

-

- transfers to stage 3

(1,444)

20 

(6,255)

765 

7,699 

(785)

-

- transfers from stage 3

379 

(16)

763 

(57)

(1,142)

73 

Net remeasurement of ECL arising from transfer of stage

354 

(294)

(45)

15 

Net new and further lending/repayments

43,282 

(138)

(32,082)

311 

(3,787)

973 

(36)

7,377 

1,149 

Change to risk parameters - credit quality

203 

(621)

(2,941)

21 

(3,338)

Changes to models used for ECL calculation

(9)

25 

16 

Assets written off

(2,596)

2,596 

-

(2,596)

2,596 

Credit-related modifications that resulted in derecognition

(119)

95 

(119)

95 

Foreign exchange and

others1

(10,818)

(9)

(696)

(25)

(184)

(29)

(8)

(16)

(11,706)

(79)

At 31 Dec 2023

845,982 

(698)

102,129 

(1,668)

16,939 

(6,207)

85 

(30)

965,135 

(8,603)

ECL income statement change for the period

410 

(579)

(2,013)

24 

(2,158)

Recoveries

42 

Others

(203)

Total ECL income statement change for the period

(2,319)

1 Total includes $13.5bn of gross carrying loans and advances to customers and banks, which were classified to assets held for sale during the year, and a corresponding allowance for ECL of $61m, reflecting business disposals as disclosed in Note 23 'Assets held for sale and liabilities of disposal groups held for sale' on page 401.

As shown in the above table, the allowance for ECL for loans and advances to customers and banks and relevant loan commitments and financial guarantees decreased by $454m during the period from $9,057m at 31 December 2022 to $8,603m at 31 December 2023.

This decrease was driven by:

- $2,596m of assets written off;

- $1,149m relating to volume movements, which included the allowance for ECL associated with new originations, assets derecognised and further lending/repayments;

- $95m relating to credit-related modification, which resulted in derecognition;

- $16m relating to changes to models used for ECL calculation; and

- $15m relating to the net remeasurement impact of stage transfers.

 

These were partly offset by:

- $3,338m of changes to models used for ECL calculation; and

- foreign exchange and other movements of $79m.

 

The ECL charge for the period of $2,158m presented in the previous table consisted of $3,338m relating to underlying credit quality changes, including the credit quality impact of financial instruments transferring between stages. This was partly offset by $1,149m relating to underlying net book volume movement, $16m in changes to models used for ECL calculation and $15m relating to the net remeasurement impact of stage transfers.

During the period, there was a net transfer to stage 2 of $15,739m gross carrying/nominal amounts. It was primarily driven by $8,792m in Hong Kong, mainly due to deterioration in the real estate and construction sectors, and $6,273m in the UK, mainly driven by increased interest rates affecting the corporate and commercial portfolio.

Wholesale lending - reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to banks and

customers including loan commitments and financial guarantees

(Audited)

Non-credit impaired

Credit impaired

Stage 1

Stage 2

Stage 3

POCI

Total

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

At 1 Jan 2022

880,181 

(860)

137,493 

(2,103)

14,685 

(5,702)

275 

(64)

1,032,634 

(8,729)

Transfers of financial instruments:

(58,104)

(298)

49,485 

942 

8,619 

(644)

- transfers from stage 1 to

stage 2

(157,443)

202 

157,443 

(202)

- transfers from stage 2 to

stage 1

100,810 

(484)

(100,810)

484 

- transfers to stage 3

(1,829)

8

(8,101)

770 

9,930 

(778)

- transfers from stage 3

358 

(24)

953 

(110)

(1,311)

134 

Net remeasurement of ECL arising from transfer of stage

240 

(369)

(63)

(192)

Net new and further lending/repayments

68,616 

(158)

(45,336)

201 

(3,253)

583 

(133)

3

19,894 

629 

Changes to risk parameters - credit quality

318 

(995)

(2,196)

32

(2,841)

Changes to models used for ECL calculation

6

(56)

(50)

Assets written off

(1,579)

1,579 

(10)

10

(1,589)

1,589 

Credit-related modifications that resulted in derecognition

(32)

9

(32)

9

Foreign exchange and others1

(60,371)

82

(16,982)

175 

(1,372)

290 

(3)

(19)

(78,728)

528 

At 31 Dec 2022

830,322 

(670)

124,660 

(2,205)

17,068 

(6,144)

129 

(38)

972,179 

(9,057)

ECL income statement change for the period

406 

(1,219)

(1,676)

35

(2,454)

Recoveries

33

Others

(25)

Total ECL income statement change for the period

(2,446)

1 Total includes $33.1bn of gross carrying loans and advances to customers and banks, which were classified to assets held for sale during the year, and a corresponding allowance for ECL of $204m, reflecting business disposals as disclosed in Note 23 'Assets held for sale and liabilities of disposal groups held for sale' on page 401.

Wholesale lending - distribution of financial instruments to which the impairment requirements of IFRS 9 are applied by credit quality

Gross carrying amount

Allowance for ECL

Net

Strong

Good

Satisfactory

Sub-

standard

Credit impaired

Total

$m

$m

$m

$m

$m

$m

$m

$m

By legal entity

HSBC UK Bank plc

20,777 

30,245 

36,206 

8,300 

3,769 

99,297 

(1,280)

98,017 

HSBC Bank plc

41,149 

20,962 

24,164 

4,202 

2,713 

93,190 

(1,249)

91,941 

The Hongkong and Shanghai Banking Corporation Limited

165,255 

72,683 

78,566 

8,774 

7,115 

332,393 

(4,251)

328,142 

HSBC Bank Middle East Limited

13,660 

3,082 

6,270 

513 

897 

24,422 

(601)

23,821 

HSBC North America Holdings Inc.

6,244 

13,668 

13,094 

3,503 

583 

37,092 

(296)

36,796 

Grupo Financiero HSBC, S.A. de C.V.

1,853 

6,543 

5,882 

622 

382 

15,282 

(326)

14,956 

Other trading entities

3,189 

1,277 

7,449 

988 

392 

13,295 

(219)

13,076 

Holding companies, shared service centres and intra-Group eliminations

33 

33 

33 

At 31 Dec 2023

252,160

148,460

171,631

26,902

15,851

615,004

(8,222)

606,782

Percentage of total credit quality (%)

41.0

24.1

27.9

4.4

2.6

100.0

 

By legal entity

HSBC UK Bank plc

17,533 

28,685 

32,388 

5,180 

4,467 

88,253 

(1,254)

86,999 

HSBC Bank plc

41,687 

21,058 

24,560 

5,044 

2,634 

94,983 

(1,312)

93,671 

The Hongkong and Shanghai Banking Corporation Limited

167,209 

81,128 

84,661 

9,732 

7,014 

349,744 

(4,439)

345,305 

HSBC Bank Middle East Limited

13,023 

4,119 

5,879 

678 

950 

24,649 

(719)

23,930 

HSBC North America Holdings Inc.

7,226 

13,220 

12,673 

4,558 

211 

37,888 

(240)

37,648 

Grupo Financiero HSBC, S.A. de C.V.

1,024 

5,540 

4,612 

772 

399 

12,347 

(335)

12,012 

Other trading entities

3,845 

2,228 

8,438 

1,594 

701 

16,806 

(347)

16,459 

At 31 Dec 2022

251,547 

155,978 

173,211 

27,558 

16,376 

624,670 

(8,646)

616,024 

Percentage of total credit quality (%)

40.3

25.0

27.7

4.4

2.6

100.0

 

 

Our risk rating system facilitates the internal ratings-based approach under the Basel framework adopted by the Group to support calculation of our minimum credit regulatory capital requirement. The credit quality classifications can be found on page 148.

Wholesale lending - credit risk profile by obligor grade for loans and advances at amortised cost

Gross carrying amount

Allowance for ECL

Basel one-year PD range

Stage 1

Stage 2

Stage 3

POCI

Total

Stage 1

Stage 2

Stage 3

POCI

Total

ECL coverage

Mapped external rating

%

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

%

Corporate and commercial

342,878 

69,738 

14,958 

81 

427,655 

(499)

(1,500)

(5,774)

(30)

(7,803)

1.8

- CRR 1

0.000 to 0.053

34,097 

715 

34,812 

(4)

(3)

(7)

-

AA- and above

- CRR 2

0.054 to 0.169

81,131 

2,180 

83,311 

(23)

(14)

(37)

-

A+ to A-

- CRR 3

0.170 to 0.740

112,322 

11,391 

123,713 

(106)

(87)

(193)

0.2

BBB+ to BBB-

- CRR 4

0.741 to 1.927

72,654 

16,904 

89,558 

(156)

(130)

(286)

0.3

BB+ to BB-

- CRR 5

1.928 to 4.914

37,631 

18,060 

55,691 

(169)

(240)

(409)

0.7

BB- to B

- CRR 6

4.915 to 8.860

2,675 

7,341 

10,016 

(24)

(176)

(200)

2.0

B-

- CRR 7

8.861 to 15.000

1,031 

6,319 

7,350 

(10)

(246)

(256)

3.5

CCC+

- CRR 81

15.001 to 99.999

1,337 

6,828 

8,165 

(7)

(604)

(611)

7.5

CCC to C

- CRR 9/10

100.000 

14,958 

81 

15,039 

(5,774)

(30)

(5,804)

38.6

D

Non-bank financial institutions

69,972 

3,650 

810 

74,432 

(52)

(30)

(322)

(404)

0.5

- CRR 1

0.000 to 0.053

15,475 

211 

15,686 

(2)

-

(2)

-

AA- and above

- CRR 2

0.054 to 0.169

16,920 

374 

17,294 

(6)

(2)

(8)

-

A+ to A-

- CRR 3

0.170 to 0.740

19,195 

912 

20,107 

(10)

(4)

(14)

0.1

BBB+ to BBB-

- CRR 4

0.741 to 1.927

11,480 

1,032 

12,512 

(19)

(5)

(24)

0.2

BB+ to BB-

- CRR 5

1.928 to 4.914

6,635 

872 

7,507 

(9)

(15)

(24)

0.3

BB- to B

- CRR 6

4.915 to 8.860

232 

116 

348 

(6)

(1)

(7)

2.0

B-

- CRR 7

8.861 to 15.000

25 

93 

118 

-

(2)

(2)

1.7

CCC+

- CRR 8

15.001 to 99.999

10 

40 

50 

-

(1)

(1)

2.0

CCC to C

- CRR 9/10

100.000 

810 

810 

(322)

(322)

39.8

D

Banks

111,479 

1,436 

112,917 

(10)

(3)

(2)

(15)

-

- CRR 1

0.000 to 0.053

89,112 

10 

89,122 

(4)

(4)

-

AA- and above

- CRR 2

0.054 to 0.169

11,899 

36 

11,935 

(2)

-

(2)

-

A+ to A-

- CRR 3

0.170 to 0.740

4,631 

4,640 

(1)

(1)

-

BBB+ to BBB-

- CRR 4

0.741 to 1.927

2,488 

58 

2,546 

(1)

-

(1)

-

BB+ to BB-

- CRR 5

1.928 to 4.914

3,062 

755 

3,817 

(2)

(1)

(3)

0.1

BB- to B

- CRR 6

4.915 to 8.860

22 

20 

42 

-

-

-

B-

- CRR 7

8.861 to 15.000

-

-

-

CCC+

- CRR 8

15.001 to 99.999

264 

548 

812 

(2)

(2)

0.2

CCC to C

- CRR 9/10

100.000 

(2)

(2)

100.0

D

At 31 Dec 2023

524,329 

74,824 

15,770 

81 

615,004 

(561)

(1,533)

(6,098)

(30)

(8,222)

1.3

1 Corporate and commercial lending reported in CRR 8 for stage 1 includes $782m related to the UK Bounce Back Loan Scheme with immaterial allowances for ECL.

 

 

Wholesale lending - credit risk profile by obligor grade for loans and advances at amortised cost (continued)

Basel one-year PD range

Gross carrying amount

Allowance for ECL

ECL coverage

Mapped external rating

Stage 1

Stage 2

Stage 3

POCI

Total

Stage 1

Stage 2

Stage 3

POCI

Total

%

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

%

Corporate and

commercial

351,885

85,492 

15,696 

129 

453,202

(488)

(1,907)

(5,887)

(38)

(8,320)

1.8

- CRR 1

0.000 to 0.053

35,574 

330 

35,904 

(6)

(1)

(7)

-

AA- and above

- CRR 2

0.054 to 0.169

87,383 

3,234 

90,617 

(28)

(15)

(43)

0.1

A+ to A-

- CRR 3

0.170 to 0.740

114,403

17,725 

132,128

(128)

(122)

(250)

0.2

BBB+ to BBB-

- CRR 4

0.741 to 1.927

74,100 

21,550 

95,650 

(155)

(210)

(365)

0.4

BB+ to BB-

- CRR 5

1.928 to 4.914

36,563 

21,628 

58,191 

(145)

(361)

(506)

0.9

BB- to B

- CRR 6

4.915 to 8.860

2,512 

9,171 

11,683 

(16)

(236)

(252)

2.2

B-

- CRR 7

8.861 to 15.000

1,164 

5,477 

6,641 

(8)

(336)

(344)

5.2

CCC+

- CRR 8

15.001 to 99.999

186 

6,377 

6,563 

(2)

(626)

(628)

9.6

CCC to C

- CRR 9/10

100.000 

15,696 

129 

15,825 

(5,887)

(38)

(5,925)

37.4

D

Non-bank financial institutions

61,737 

4,718 

469 

66,924 

(43)

(77)

(137)

(257)

0.4

- CRR 1

0.000 to 0.053

15,082 

421 

15,503 

(2)

(1)

(3)

-

AA- and above

- CRR 2

0.054 to 0.169

16,351 

497 

16,848 

(3)

(1)

(4)

-

A+ to A-

- CRR 3

0.170 to 0.740

17,253 

1,764 

19,017 

(9)

(13)

(22)

0.1

BBB+ to BBB-

- CRR 4

0.741 to 1.927

7,059 

717 

7,776 

(19)

(4)

(23)

0.3

BB+ to BB-

- CRR 5

1.928 to 4.914

5,215 

736 

5,951 

(10)

(10)

(20)

0.3

BB- to B

- CRR 6

4.915 to 8.860

716 

90

806 

(4)

(4)

0.5

B-

- CRR 7

8.861 to 15.000

46

32

78

(3)

(3)

3.9

CCC+

- CRR 8

15.001 to 99.999

15

461 

476 

(41)

(41)

8.6

CCC to C

- CRR 9/10

100.000 

469 

469 

(137)

(137)

29.2

D

Banks

102,723

1,739 

82

104,544

(18)

(29)

(22)

(69)

0.1

- CRR 1

0.000 to 0.053

79,217 

120 

79,337 

(8)

(8)

-

AA- and above

- CRR 2

0.054 to 0.169

13,160 

178 

13,338 

(2)

(2)

-

A+ to A-

- CRR 3

0.170 to 0.740

4,465 

368 

4,833 

(3)

(3)

0.1

BBB+ to BBB-

- CRR 4

0.741 to 1.927

2,154 

5

2,159 

(1)

(1)

0.1

BB+ to BB-

- CRR 5

1.928 to 4.914

3,312 

172 

3,484 

(4)

(1)

(5)

0.1

BB- to B

- CRR 6

4.915 to 8.860

5

5

-

B-

- CRR 7

8.861 to 15.000

1

861 

862 

(27)

(27)

3.1

CCC+

- CRR 8

15.001 to 99.999

414 

30

444 

(1)

(1)

0.2

CCC to C

- CRR 9/10

100.000 

82

82

(22)

(22)

26.8

D

At 31 Dec 2022

516,345

91,949 

16,247 

129 

624,670

(549)

(2,013)

(6,046)

(38)

(8,646)

1.4

 

Wholesale lending - credit risk profile by obligor grade for loan and other credit-related commitments and financial guarantees

Nominal amount

Allowance for ECL

Basel one-year PD range

Stage 1

Stage 2

Stage 3

POCI

Total

Stage 1

Stage 2

Stage 3

POCI

Total

ECL coverage

Mapped external rating

%

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

%

Loan and other credit-related commitments

377,766 

25,463 

785 

404,018

(130)

(128)

(84)

(342)

0.1

- CRR 1

0.000 to 0.053

65,730 

1,676 

67,406 

(5)

(1)

-

(6)

-

AA- and above

- CRR 2

0.054 to 0.169

152,224 

2,490 

154,714

(13)

(6)

(19)

-

A+ to A-

- CRR 3

0.170 to 0.740

105,569 

6,044 

111,613

(46)

(24)

(70)

0.1

BBB+ to BBB-

- CRR 4

0.741 to 1.927

38,102 

4,751 

42,853 

(33)

(20)

-

(53)

0.1

BB+ to BB-

- CRR 5

1.928 to 4.914

14,054 

5,367 

19,421 

(28)

(31)

(59)

0.3

BB- to B

- CRR 6

4.915 to 8.860

1,170 

2,453 

3,623 

(4)

(15)

(19)

0.5

B-

- CRR 7

8.861 to 15.000

780 

848 

1,628 

(1)

(10)

(11)

0.7

CCC+

- CRR 8

15.001 to 99.999

137 

1,834 

1,971 

-

(21)

(21)

1.1

CCC to C

- CRR 9/10

100.000 

785 

789 

-

(84)

(84)

10.6

D

Financial guarantees

13,640 

1,866 

384 

15,890 

(7)

(7)

(25)

(39)

0.2

- CRR 1

0.000 to 0.053

2,553 

2,554 

-

-

AA- and above

- CRR 2

0.054 to 0.169

4,212 

202 

4,414 

(1)

-

(1)

-

A+ to A-

- CRR 3

0.170 to 0.740

3,584 

202 

3,786 

(2)

-

(2)

0.1

BBB+ to BBB-

- CRR 4

0.741 to 1.927

1,932 

407 

2,339 

(2)

(1)

(3)

0.1

BB+ to BB-

- CRR 5

1.928 to 4.914

1,266 

455 

1,721 

(2)

(2)

(4)

0.2

BB- to B

- CRR 6

4.915 to 8.860

91 

387 

478 

-

(1)

(1)

0.2

B-

- CRR 7

8.861 to 15.000

76 

77 

-

-

-

CCC+

- CRR 8

15.001 to 99.999

136 

137 

(3)

(3)

2.2

CCC to C

- CRR 9/10

100.000 

384 

384 

(25)

(25)

6.5

D

At 31 Dec 2023

391,406 

27,329 

1,169 

419,908

(137)

(135)

(109)

(381)

0.1

 

 

Commercial real estate

Commercial real estate lending includes the financing of corporate, institutional and high net worth customers who are investing primarily in income-producing assets and, to a lesser extent, in their construction and development. The portfolio has larger concentrations in Hong Kong, the UK, mainland China and the US.

Our global exposure is centred largely on cities with economic, political or cultural significance. In more developed markets, our exposure mainly comprises the financing of investment assets, the redevelopment of existing stock and the augmentation of both commercial and residential markets to support economic and population growth. In less developed commercial real estate markets, our exposures comprise lending for development assets on relatively

short tenors with a particular focus on supporting larger, better capitalised developers involved in residential construction or assets supporting economic expansion.

Excluding favourable foreign exchange movements of $1.1bn, commercial real estate lending decreased by $13.8bn, mainly from $7.4bn in Hong Kong due to loan repayments. The decrease included loan sales of $0.5bn in the US as part of an initiative to reduce the portfolio exposure.

Despite the lower exposure, allowance for ECL remained at $2.8bn, reflecting the challenging conditions in the commercial property sector, including the impact of lower valuations in the office segment.

Commercial real estate lending to customers

of which:

HSBC UK Bank plc

HSBC Bank plc

The Hongkong and Shanghai Banking Corporation Limited

HSBC Bank Middle East Limited

HSBC North America Holdings Inc.1

Grupo Financiero HSBC, S.A. de C.V.

Other trading entities

Total

UK

Hong Kong

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

Gross loans and advances

Stage 1

10,304 

4,218 

41,307 

1,126 

1,803 

685 

440 

59,883 

10,790 

28,846 

Stage 2

3,262 

400 

13,229 

189 

1,956 

70 

19,107 

3,294 

10,375 

Stage 3

444 

184 

3,570 

145 

166 

25 

18 

4,552 

470 

3,226 

POCI

32 

15 

47 

32 

15 

At 31 Dec 2023

14,010 

4,834 

58,121 

1,460 

3,925 

780 

459 

83,589 

14,586 

42,462 

- of which: 

forborne loans

461 

69 

2,454 

126 

433 

52 

3,595 

519 

2,227 

Allowance for ECL

(148)

(49)

(2,399)

(55)

(98)

(15)

(10)

(2,774)

(172)

(2,149)

 

Gross loans and advances

Stage 1

11,409 

5,083 

46,700 

1,094 

2,096 

832 

906 

68,120 

12,209 

35,905 

Stage 2

2,763 

828 

16,311 

323 

3,249 

43

91

23,608 

3,008 

11,068 

Stage 3

702 

277 

3,320 

264 

28

57

4,648 

827 

3,029 

POCI

19

19

19

At 31 Dec 2022

14,874 

6,188 

66,350 

1,681 

5,345 

903 

1,054 

96,395 

16,044 

50,021 

- of which:

forborne loans

215 

143 

763 

449 

428 

47

23

2,068 

336 

654 

Allowance for ECL

(216)

(153)

(2,094)

(153)

(93)

(24)

(13)

(2,746)

(323)

(1,878)

1 During 1Q23, we aligned the classification of commercial real estate across the Group and re-presented commercial real estate exposure in HSBC North America Holdings Inc. at 31 December 2022 as $5.3bn, which had a corresponding ECL charge of $0.1bn.

Commercial real estate lending to customers by global business

of which:

HSBC UK Bank plc

HSBC Bank plc

The Hongkong and Shanghai Banking Corporation Limited

HSBC Bank Middle East Limited

HSBC North America Holdings Inc.

Grupo Financiero HSBC, S.A. de C.V.

Other trading entities

Total

UK

Hong Kong

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

Wealth and Personal Banking

409 

377 

66 

423 

1,277 

409 

66 

Commercial Banking

13,601 

3,322 

37,826 

733 

3,923 

780 

36 

60,221 

13,686 

27,811 

Global Banking and Markets

1,135 

20,066 

727 

21,928 

491 

14,444 

Corporate Centre

163 

163 

141 

At 31 Dec 2023

14,010 

4,834 

58,121 

1,460 

3,925 

780 

459 

83,589 

14,586 

42,462 

of which:

HSBC UK Bank plc

HSBC Bank plc

The Hongkong and Shanghai Banking Corporation Limited

HSBC Bank Middle East Limited

HSBC North America Holdings Inc.

Grupo Financiero HSBC, S.A. de C.V.

Other trading entities

Total

UK

Hong

Kong

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

Wealth and Personal Banking

532 

70 

826 

1,434 

534 

70 

Commercial Banking

14,342 

4,390 

42,803 

951 

5,341 

903 

205 

68,935 

14,638 

33,123 

Global Banking and Markets

1,796 

23,333 

730 

23 

25,882 

872 

16,684 

Corporate Centre

144 

144 

144 

At 31 Dec 2022

14,874 

6,188 

66,350 

1,681 

5,345 

903 

1,054 

96,395 

16,044 

50,021 

 

Commercial real estate lending to customers by credit quality

of which:

HSBC UK Bank plc

HSBC Bank plc

The Hongkong and Shanghai Banking Corporation Limited

HSBC Bank Middle East Limited

HSBC North America Holdings Inc.

Grupo Financiero HSBC, S.A. de C.V.

Other trading entities

Total

UK

Hong Kong

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

Strong

3,940 

740 

12,394 

255 

25 

65 

16 

17,435 

4,191 

6,527 

Good

2,555 

2,054 

17,777 

246 

781 

130 

18 

23,561 

2,592 

12,004 

Satisfactory

6,370 

1,642 

19,509 

634 

1,691 

500 

407 

30,753 

6,575 

16,290 

Sub-standard

701 

182 

4,856 

180 

1,262 

60 

7,241 

726 

4,400 

Credit impaired

444 

216 

3,585 

145 

166 

25 

18 

4,599 

502 

3,241 

At 31 Dec 2023

14,010 

4,834 

58,121 

1,460 

3,925 

780 

459 

83,589 

14,586 

42,462 

Strong

3,951 

1,444 

16,063 

303 

352 

29 

72 

22,214 

4,681 

10,061 

Good

3,094 

1,448 

20,692 

359 

864 

190 

26,651 

3,244 

15,209 

Satisfactory

6,819 

2,647 

20,930 

539 

2,397 

616 

881 

34,829 

6,959 

16,775 

Sub-standard

308 

372 

5,326 

216 

1,732 

40 

40 

8,034 

333 

4,928 

Credit impaired

702 

277 

3,339 

264 

28 

57 

4,667 

827 

3,048 

At 31 Dec 2022

14,874 

6,188 

66,350 

1,681 

5,345 

903 

1,054 

96,395 

16,044 

50,021 

 

Refinance risk in commercial real estate

Commercial real estate lending tends to require the repayment of a significant proportion of the principal at maturity. Typically, a customer will arrange repayment through the acquisition of a new loan to settle the existing debt. Refinance risk is the risk that a customer, being

unable to repay the debt on maturity, fails to refinance it at commercial terms. We monitor our commercial real estate portfolio closely, assessing indicators for signs of potential issues with refinancing.

Commercial real estate gross loans and advances to customers maturity analysis

of which:

HSBC UK Bank plc

HSBC Bank plc

The Hongkong and Shanghai Banking Corporation Limited

HSBC Bank Middle East Limited

HSBC North America Holdings Inc.1

Grupo Financiero HSBC, S.A. de C.V.

Other trading entities

Total

UK

Hong Kong

$m

$m

$m

$m

$m

$m

$m

$m

$m

$m

< 1 year

3,553 

1,496 

25,427 

396 

1,472 

619 

437 

33,400 

3,950 

19,887 

1-2 years

4,514 

474 

14,144 

175 

623 

60 

19,992 

4,571 

10,923 

2-5 years

5,411 

2,149 

16,052 

441 

1,814 

71 

25,941 

5,520 

9,885 

> 5 years

532 

715 

2,498 

448 

16 

30 

17 

4,256 

545 

1,767 

At 31 Dec 2023

14,010 

4,834 

58,121 

1,460 

3,925 

780 

459 

83,589 

14,586 

42,462 

 

< 1 year

8,315 

2,059 

23,468 

423 

1,883 

241 

703 

37,092 

9,211 

18,675 

1-2 years

3,518 

1,503 

18,007 

218 

810 

115 

228 

24,399 

3,678 

13,873 

2-5 years

2,385 

1,644 

21,804 

664 

2,624 

449 

60

29,630 

2,472 

14,963 

> 5 years

656 

982 

3,071 

376 

28

98

63

5,274 

683 

2,510 

At 31 Dec 2022

14,874 

6,188 

66,350 

1,681 

5,345 

903 

1,054 

96,395 

16,044 

50,021 

1 During 1Q23, we aligned the classification of commercial real estate across the Group and re-presented commercial real estate exposure in HSBC North America Holdings Inc. at 31 December 2022 as $5.3bn, which had a corresponding ECL charge of $0.1bn.

 

The following table presents the Group's exposure to borrowers classified in the commercial real estate sector where the ultimate parent is based in mainland China, as well as all commercial real estate exposures booked on mainland China balance sheets.

The exposures at 31 December 2023 are split by country/territory and credit quality including allowances for ECL by stage.

Mainland China commercial real estate

(Audited)

Hong Kong

Mainland China

Rest of the Group

Total

$m

$m

$m

$m

Loans and advances to customers1

6,033 

4,917 

839 

11,789 

Guarantees issued and others2

255 

66 

37 

358 

Total mainland China commercial real estate exposure at 31 Dec 2023

6,288 

4,983 

876 

12,147 

Distribution of mainland China commercial real estate exposure by credit quality

Strong

781 

1,723 

2,510 

Good

604 

953 

421 

1,978 

Satisfactory

679 

1,704 

261 

2,644 

Sub-standard

1,298 

327 

188 

1,813 

Credit impaired

2,926 

276 

3,202 

At 31 Dec 2023

6,288 

4,983 

876 

12,147 

Allowance for ECL by credit quality

Strong

(3)

(3)

Good

(5)

(1)

(6)

Satisfactory

(3)

(27)

(30)

Sub-standard

(66)

(87)

(16)

(169)

Credit impaired

(1,726)

(125)

(1,851)

At 31 Dec 2023

(1,795)

(247)

(17)

(2,059)

Allowance for ECL by stage distribution

Stage 1

(10)

(10)

Stage 2

(69)

(112)

(17)

(198)

Stage 3

(1,726)

(125)

(1,851)

At 31 Dec 2023

(1,795)

(247)

(17)

(2,059)

ECL coverage %

28.5

5.0

1.9

17.0

1 Amounts represent gross carrying amount.

2 Amounts represent nominal amount for guarantees and other contingent liabilities.

 

 

Mainland China commercial real estate (continued)

Hong Kong

Mainland China

Rest of the Group

Total

(audited)1

(audited)2

(unaudited)1

(unaudited)2

$m

$m

$m

$m

Loans and advances to customers2

9,129 

5,752 

860 

15,741 

Guarantees issued and others3

249 

755 

18

1,022 

Total mainland China commercial real estate exposure at 31 Dec 2022

9,378 

6,507 

878 

16,763 

Distribution of mainland China commercial real estate exposure by credit quality

Strong

1,425 

2,118 

220 

3,763 

Good

697 

1,087 

370 

2,154 

Satisfactory

1,269 

2,248 

77

3,594 

Sub-standard

2,887 

779 

193 

3,859 

Credit impaired

3,100 

275 

18

3,393 

At 31 Dec 2022

9,378 

6,507 

878 

16,763 

Allowance for ECL by credit quality

Strong

(5)

(5)

Good

(8)

(1)

(9)

Satisfactory

(20)

(81)

(101)

Sub-standard

(458)

(42)

(3)

(503)

Credit impaired

(1,268)

(105)

(1,373)

At 31 Dec 2022

(1,746)

(241)

(4)

(1,991)

Allowance for ECL by stage distribution

Stage 1

(1)

(9)

(1)

(11)

Stage 2

(477)

(127)

(3)

(607)

Stage 3

(1,268)

(105)

(1,373)

At 31 Dec 2022

(1,746)

(241)

(4)

(1,991)

ECL coverage %

18.6

3.7

0.5

11.9

1 Disclosures in respect of mainland China commercial real estate exposures in Hong Kong and mainland China form part of the scope of the audit of the Group's Annual Report and Accounts 2022. Amounts disclosed for mainland China commercial real estate exposures elsewhere in the Group have not been audited but are provided for completeness.

2 Amounts represent gross carrying amount.

3 Amounts represent nominal amount for guarantees and other contingent liabilities.

(Unaudited)

Commercial real estate financing refers to lending that focuses on commercial development and investment in real estate and covers commercial, residential and industrial assets. The exposures in the table are related to companies whose primary activities are focused on these activities. Lending is generally focused on tier 1 and 2 cities. The table also includes financing provided to a corporate or financial entity for the purchase or financing of a property that supports the overall operations of the business. Such exposures are outside of our normal definition of commercial real estate, as applied elsewhere in this report, but are provided here for a more comprehensive view of our mainland China property exposure.

The table above shows 59% ($7.1bn) of total exposure with a credit quality of 'satisfactory' or above, which was slightly higher in proportion compared with 31 December 2022 (57%, $9.5bn). Total 'credit impaired' exposures increased to 26% ($3.2bn) (31 December 2022: 20%, $3.4bn), reflecting sustained stress in the China commercial real estate market, including weakness in both property market fundamentals and financing conditions for borrowers operating in this sector.

Allowances for ECL are substantially against unsecured exposures. For secured exposures, allowances for ECL are minimal, reflecting the nature and value of the security held.

Facilities booked in Hong Kong continued to represent the largest proportion of mainland China commercial real estate exposures, although total exposures reduced to $6.3bn, down $3.1bn since 31 December 2022, as a result of de-risking measures, repayments

and write-offs. This portfolio remains relatively higher risk, with 33% (31 December 2022: 36%) of exposure booked with a credit quality of 'satisfactory' or above and 47% 'credit impaired' (31 December 2022: 33%).

At 31 December 2023, the Group had allowances for ECL of $1.8bn (31 December 2022: $1.7bn) held against mainland China commercial real estate exposures booked in Hong Kong. ECL coverage increased to 28.5% (31 December 2022: 18.6%), reflecting a further credit deterioration during the year.

Approximately half of the unimpaired exposure in the Hong Kong portfolio is lending to state-owned enterprises and relatively strong private-owned enterprises. This is reflected in the relatively low allowance for ECL in this part of the portfolio.

Market conditions are likely to remain subdued with a protracted recovery as sentiment and domestic residential demand remain weak, with ongoing refinancing and liquidity risk for corporates operating in this market. The divergence between privately-owned enterprises and state-owned enterprises is likely to continue, with state-owned enterprises achieving above-market sales performance, and benefiting from market share gains and better access to funding.

The Group has additional exposures to mainland China commercial real estate as a result of lending to multinational corporates booked outside of mainland China, which is not incorporated in the table above.

Collateral and other credit enhancements

(Audited)

Although collateral can be an important mitigant of credit risk, it is the Group's practice to lend on the basis of the customer's ability to meet their obligations out of cash flow resources rather than placing primary reliance on collateral and other credit risk enhancements. Depending on the customer's standing and the type of product, facilities may be provided without any collateral or other credit enhancements. For other lending, a charge over collateral is obtained and considered in determining the credit decision and pricing. In the event of default, the Group may utilise the collateral as a source of repayment.

Depending on its form, collateral can have a significant financial effect in mitigating our exposure to credit risk. Where there is sufficient collateral, an expected credit loss is not recognised. This is the case for reverse repurchase agreements and for certain loans and advances to customers where the loan to value ('LTV') is very low.

Mitigants may include a charge on borrowers' specific assets, such as real estate or financial instruments. Other credit risk mitigants include short positions in securities and financial assets held as part of linked insurance/investment contracts where the risk is predominantly borne by the policyholder. Additionally, risk may be managed by employing other types of collateral and credit risk enhancements, such as second charges, other liens and unsupported guarantees. Guarantees are normally taken from corporates and export credit agencies. Corporates would normally provide guarantees as part of a parent/subsidiary relationship and span a number of credit grades. The export credit agencies will normally be investment grade.

Certain credit mitigants are used strategically in portfolio management activities. While single name concentrations arise in portfolios managed by Global Banking and Corporate Banking, it is only in Global Banking that their size requires the use of portfolio level credit mitigants. Across Global Banking, risk limits and utilisations, maturity profiles and risk quality are monitored and managed proactively. This process is key to the setting of risk appetite for these larger, more complex, geographically distributed customer groups. While the principal form of risk management continues to be at the point of exposure origination, through the lending decision-making process, Global Banking also utilises loan sales and credit default swap ('CDS') hedges to manage concentrations and reduce risk.

These transactions are the responsibility of a dedicated Global Banking portfolio management team. Hedging activity is carried out within agreed credit parameters, and is subject to market risk limits and a robust governance structure. Where applicable, CDSs are entered into directly with a central clearing house counterparty. Otherwise, the Group's exposure to CDS protection providers is diversified among mainly banking counterparties with strong credit ratings.

CDS mitigants are held at portfolio level and are not included in the expected credit loss calculations. CDS mitigants are not reported in the following tables.

 

Collateral on loans and advances

Collateral held is analysed separately for commercial real estate and for other corporate, commercial and financial (non-bank) lending. The following tables include off-balance sheet loan commitments, primarily undrawn credit lines.

The collateral measured in the following tables consists of fixed first charges on real estate, and charges over cash and marketable financial instruments. The values in the tables represent the expected market value on an open market basis. No adjustment has been made to the collateral for any expected costs of recovery. Marketable securities are measured at their fair value.

Other types of collateral such as unsupported guarantees and floating charges over the assets of a customer's business are not measured in the following tables. While such mitigants have value, often providing rights in insolvency, their assignable value is not sufficiently certain and they are therefore assigned no value for disclosure purposes.

The LTV ratios presented are calculated by directly associating loans and advances with the collateral that individually and uniquely supports each facility. When collateral assets are shared by multiple loans and advances, whether specifically or, more generally, by way of an all monies charge, the collateral value is pro-rated across the loans and advances protected by the collateral.

For credit-impaired loans, the collateral values cannot be directly compared with impairment allowances recognised. The LTV figures use open market values with no adjustments. Impairment allowances are calculated on a different basis, by considering other cash flows and adjusting collateral values for costs of realising collateral as explained further on page 348.

Commercial real estate loans and advances

The value of commercial real estate collateral is determined by using a combination of external and internal valuations and physical inspections. For commercial real estate, where the facility exceeds regulatory threshold requirements, Group policy requires an independent review of the valuation at least every three years, or more frequently as the need arises.

In Hong Kong, market practice is typically for lending to major property companies to be either secured by guarantees or unsecured. In Europe, facilities of a working capital nature are generally not secured by a first fixed charge, and are therefore disclosed as not collateralised.

 

Wholesale lending - commercial real estate loans and advances to customers including loan commitments by level of collateral for key

countries/territories (by stage)

(Audited)

Gross carrying/nominal amount

ECL coverage

Stage 1

Stage 2

Stage 3

POCI

Total

Stage 1

Stage 2

Stage 3

POCI

Total

$m

$m

$m

$m

$m

%

%

%

%

%

Not collateralised

36,754 

5,128 

2,543 

44,425 

0.1

3.9

72.4

-

4.7

Fully collateralised by LTV ratio

46,212 

15,177 

1,963 

63,352 

0.1

2.5

12.0

-

1.0

- less than 50%

24,391 

7,413 

574 

32,378 

0.1

1.9

13.1

-

0.7

- 51% to 75%

16,086 

5,240 

657 

21,983 

0.1

3.1

9.3

-

1.1

- 76% to 90%

3,140 

1,437 

454 

5,031 

0.1

3.5

11.8

-

2.1

- 91% to 100%

2,595 

1,087 

278 

3,960 

0.2

2.3

16.6

-

1.9

Partially collateralised (A): LTV > 100%

7,075 

1,487 

156 

50 

8,768 

0.1

1.8

30.2

14.5

1.0

- collateral value on A

4,004 

1,061 

115 

26 

5,206 

Total at 31 Dec 2023

90,041 

21,792 

4,662 

50 

116,545 

0.1

2.8

45.6

14.5

2.4

of which: UK

Not collateralised

4,644 

1,288 

97 

6,029 

0.4

2.0

12.4

-

0.9

Fully collateralised by LTV ratio

9,762 

2,512 

295 

12,569 

0.1

1.3

13.9

-

0.7

- less than 50%

3,514 

507 

51 

4,072 

0.1

1.9

21.6

-

0.6

- 51% to 75%

4,826 

1,418 

103 

6,347 

0.1

1.1

16.4

-

0.6

- 76% to 90%

749 

292 

80 

1,121 

0.1

1.3

14.9

-

1.5

- 91% to 100%

673 

295 

61 

1,029 

0.1

1.6

1.9

-

0.6

Partially collateralised (B): LTV > 100%

1,580 

239 

82 

35 

1,936 

0.1

1.1

34.2

20.7

2.0

- collateral value on B

524 

171 

62 

17 

774 

Total UK at 31 Dec 2023

15,986 

4,039 

474 

35 

20,534 

0.2

1.5

17.1

20.7

0.9

of which: Hong Kong

Not collateralised

16,889 

2,323 

2,215 

21,427 

-

6.5

78.7

-

8.8

Fully collateralised by LTV ratio

20,783 

8,447 

989 

30,219 

-

2.1

5.0

-

0.8

- less than 50%

15,425 

5,604 

294 

21,323 

-

1.5

1.4

-

0.5

- 51% to 75%

4,102 

2,140 

312 

6,554 

0.1

3.8

2.1

-

1.4

- 76% to 90%

657 

619 

315 

1,591 

0.1

1.8

8.0

-

2.3

- 91% to 100%

599 

84 

68 

751 

-

0.1

20.5

-

1.9

Partially collateralised (C): LTV > 100%

1,770 

616 

52 

15 

2,453 

-

0.8

24.5

-

0.7

- collateral value on C

1,569 

535 

39 

2,151 

Total Hong Kong at 31 Dec 2023

39,442 

11,386 

3,256 

15 

54,099 

-

2.9

55.5

-

4.0

Not collateralised

43,987 

9,779 

2,612 

56,378 

0.1

5.7

53.7

-

3.6

Fully collateralised by LTV ratio

54,003 

17,619 

1,617 

73,239 

0.1

1.8

10.9

-

0.7

- less than 50%

29,635 

6,523 

544 

36,702 

0.1

1.9

16.5

-

0.7

- 51% to 75%

18,664 

8,312 

594 

27,570 

0.1

1.3

4.4

-

0.5

- 76% to 90%

3,220 

911 

315 

4,446 

0.1

2.1

4.1

-

0.8

- 91% to 100%

2,484 

1,873 

164 

4,521 

0.2

3.5

28.7

-

2.6

Partially collateralised (A): LTV > 100%

4,965 

1,924 

513 

19 

7,421 

0.1

2.2

54.2

-

4.4

- collateral value on A

2,804 

1,192 

293 

4,297 

Total at 31 Dec 20221

102,955 

29,322 

4,742 

19 

137,038 

0.1

3.1

39.1

-

2.1

of which: UK

Not collateralised

5,960 

2,511 

295 

8,766 

0.3

1.5

35.3

-

1.8

Fully collateralised by LTV ratio

10,293 

2,025 

372 

12,690 

0.1

0.9

6.5

-

0.4

- less than 50%

2,900 

664 

53 

3,617 

0.2

0.9

3.8

-

0.4

- 51% to 75%

6,361 

1,197 

291 

7,849 

0.1

0.9

2.1

-

0.3

- 76% to 90%

556 

140 

11 

707 

0.2

1.4

18.2

-

0.7

- 91% to 100%

476 

24 

17 

517 

0.2

0.4

76.5

-

2.8

Partially collateralised (B): LTV > 100%

1,920 

179 

176 

2,275 

0.2

1.1

68.8

-

5.5

- collateral value on B

1,113 

144 

72 

1,329 

Total UK at 31 Dec 2022

18,173 

4,715 

843 

23,731 

0.2

1.3

29.5

-

1.5

of which: Hong Kong

Not collateralised

20,263 

4,648 

2,123 

27,034 

-

10.6

56.9

-

6.3

Fully collateralised by LTV ratio

27,892 

7,457 

864 

36,213 

-

1.1

5.2

-

0.4

- less than 50%

21,185 

3,539 

318 

25,042 

-

1.4

2.2

-

0.3

- 51% to 75%

5,365 

3,536 

205 

9,106 

0.1

1.0

3.4

-

0.5

- 76% to 90%

995 

134 

264 

1,393 

-

0.1

1.9

-

0.4

- 91% to 100%

347 

248 

77 

672 

-

0.2

32.5

-

3.9

Partially collateralised (C): LTV > 100%

804 

390 

73 

19 

1,286 

-

2.8

61.6

-

4.4

- collateral value on C

584 

249 

39 

880 

Total Hong Kong at 31 Dec 2022

48,959 

12,495 

3,060 

19 

64,533 

-

4.7

42.5

-

2.9

1 During 1Q23, we aligned the classification of commercial real estate across the Group and re-presented commercial real estate exposure in HSBC North America Holdings Inc. at 31 December 2022 as $5.3bn, which had a corresponding ECL charge of $0.1bn.

Other corporate, commercial and financial (non-bank) loans and advances

Other corporate, commercial and financial (non-bank) loans are analysed separately in the following table, which focuses on the countries/territories containing the majority of our loans and advances balances. For financing activities in other corporate and commercial lending, collateral value is not strongly correlated to principal repayment performance.

Collateral values are generally refreshed when an obligor's general credit performance deteriorates and we have to assess the likely performance of secondary sources of repayment should it prove necessary to rely on them.

Wholesale lending - other corporate, commercial and financial (non-bank) loans and advances including loan commitments by level

of collateral for key countries/territories (by stage)

(Audited)

Gross carrying/nominal amount

ECL coverage

Stage 1

Stage 2

Stage 3

POCI

Total

Stage 1

Stage 2

Stage 3

POCI

Total

$m

$m

$m

$m

$m

%

%

%

%

%

Not collateralised

672,142 

76,261 

7,702 

756,113 

0.1

0.9

40.0

6.8

0.6

Fully collateralised by LTV ratio

113,339 

19,747 

2,629 

23 

135,738 

0.1

1.4

10.7

89.8

0.5

- less than 50%

42,953 

7,069 

1,168 

51,190 

0.1

1.5

11.8

-

0.5

- 51% to 75%

24,011 

8,222 

887 

33,120 

0.1

1.3

6.4

-

0.6

- 76% to 90%

10,194 

2,531 

421 

23 

13,169 

0.1

1.6

10.3

90.6

0.9

- 91% to 100%

36,181 

1,925 

153 

38,259 

-

1.1

27.6

-

0.2

Partially collateralised (A): LTV > 100%

53,686 

9,019 

2,233 

64,941 

0.1

0.7

32.2

38.4

1.3

- collateral value on A

24,505 

4,266 

993 

29,765 

Total at 31 Dec 2023

839,167 

105,027 

12,564 

34 

956,792 

0.1

1.0

32.5

67.1

0.6

of which: UK

Not collateralised

117,824 

20,401 

3,423 

141,648 

0.2

1.9

23.2

-

1.0

Fully collateralised by LTV ratio

22,217 

5,912 

1,162 

29,291 

0.1

1.7

3.7

-

0.6

- less than 50%

7,385 

2,340 

601 

10,326 

0.1

1.2

1.3

-

0.5

- 51% to 75%

6,966 

2,292 

434 

9,692 

0.1

1.7

3.6

-

0.7

- 76% to 90%

2,256 

809 

106 

3,171 

0.2

2.5

15.8

-

1.3

- 91% to 100%

5,610 

471 

21 

6,102 

0.1

2.1

14.5

-

0.3

Partially collateralised (B): LTV > 100%

6,335 

1,732 

299 

8,366 

0.2

1.8

18.4

-

1.2

- collateral value on B

3,508 

1,080 

175 

4,763 

Total UK at 31 Dec 2023

146,376 

28,045 

4,884 

179,305 

0.2

1.8

18.3

-

0.9

of which: Hong Kong

Not collateralised

114,025 

7,523 

906 

122,454 

-

0.4

57.5

-

0.5

Fully collateralised by LTV ratio

32,857 

8,918 

877 

22 

42,674 

0.1

1.3

6.6

94.7

0.5

- less than 50%

16,175 

2,898 

230 

19,303 

0.1

1.4

11.8

-

0.4

- 51% to 75%

9,461 

4,515 

336 

14,312 

0.1

1.2

3.1

-

0.5

- 76% to 90%

4,245 

863 

253 

22 

5,383 

0.1

1.8

2.0

94.7

0.9

- 91% to 100%

2,976 

642 

58 

3,676 

-

0.4

27.0

-

0.5

Partially collateralised (C): LTV > 100%

16,152 

2,887 

704 

19,743 

-

0.6

30.2

-

1.2

- collateral value on C

6,619 

1,306 

318 

8,243 

Total Hong Kong at 31 Dec 2023

163,034 

19,328 

2,487 

22 

184,871 

0.1

0.8

31.8

94.7

0.6

Not collateralised

632,889 

79,009 

8,278 

64 

720,240 

0.1

1.1

38.4

18.8

0.6

Fully collateralised by LTV ratio

94,789 

27,422 

1,948 

24 

124,183 

0.1

1.1

13.7

91.7

0.5

- less than 50%

36,747 

10,643 

678 

48,068 

0.1

1.1

18.6

-

0.6

- 51% to 75%

29,108 

10,457 

503 

40,069 

0.1

1.2

11.3

-

0.5

- 76% to 90%

9,643 

2,987 

402 

23 

13,055 

0.1

1.0

4.7

95.7

0.6

- 91% to 100%

19,291 

3,335 

365 

22,991 

0.1

0.8

17.5

-

0.4

Partially collateralised (A): LTV > 100%

54,794 

12,830 

2,120 

22 

69,766 

0.1

0.9

37.3

18.2

1.4

- collateral value on A

27,775 

6,289 

1,133 

16 

35,213 

-

-

-

-

-

Total at 31 Dec 2022

782,472 

119,261 

12,346 

110 

914,189 

0.1

1.0

34.3

34.6

0.7

of which: UK

Not collateralised

105,126 

16,886 

3,783 

28 

125,823 

0.1

2.2

17.8

3.6

0.9

Fully collateralised by LTV ratio

21,192 

6,511 

699 

28,402 

0.1

1.3

4.6

-

0.5

- less than 50%

6,928 

2,872 

175 

9,975 

0.1

1.0

3.4

-

0.5

- 51% to 75%

7,611 

2,656 

336 

10,603 

0.1

1.5

6.5

-

0.6

- 76% to 90%

1,889 

578 

102 

2,569 

0.1

1.9

1.0

-

0.5

- 91% to 100%

4,764 

405 

86 

5,255 

-

1.2

3.5

-

0.2

Partially collateralised (B): LTV > 100%

6,480 

2,288 

308 

9,076 

0.1

1.2

25.6

-

1.2

- collateral value on B

3,470 

1,197 

158 

4,825 

-

-

-

-

Total UK at 31 Dec 2022

132,798 

25,685 

4,790 

28 

163,301 

0.1

1.9

16.4

3.6

0.9

of which: Hong Kong

Not collateralised

109,919 

9,901 

939 

120,759 

-

0.7

56.0

-

0.5

Fully collateralised by LTV ratio

38,083 

12,693 

665 

24 

51,465 

0.1

1.0

3.8

91.7

0.4

- less than 50%

15,695 

4,577 

175 

20,447 

0.1

0.9

1.7

-

0.3

- 51% to 75%

13,893 

5,413 

115 

19,422 

0.1

1.2

7.8

-

0.5

- 76% to 90%

4,964 

1,479 

268 

23 

6,734 

0.1

0.7

0.4

95.7

0.6

- 91% to 100%

3,531 

1,224 

107 

4,862 

0.1

0.3

10.3

-

0.3

Partially collateralised (C): LTV > 100%

17,704 

3,379 

777 

14 

21,874 

0.1

0.6

30.9

-

1.2

- collateral value on C

7,737 

1,524 

397 

13 

9,671 

-

-

-

-

Total Hong Kong at 31 Dec 2022

165,706 

25,973 

2,381 

38 

194,098 

0.1

0.8

33.2

57.9

0.6

 

Other credit risk exposures

In addition to collateralised lending, other credit enhancements are employed and methods used to mitigate credit risk arising from financial assets. These are summarised below:

- Some securities issued by governments, banks and other financial institutions benefit from additional credit enhancements provided by government guarantees that cover the assets.

- Debt securities issued by banks and financial institutions include asset-backed securities ('ABSs') and similar instruments, which are supported by underlying pools of financial assets. Credit risk associated with ABSs is reduced through the purchase of credit default swap ('CDS') protection.

- Trading loans and advances mainly pledged against cash collateral are posted to satisfy margin requirements. There is limited credit risk on cash collateral posted since in the event of default of the counterparty this would be set off against the related liability. Reverse repos and stock borrowing are by their nature collateralised.

Collateral accepted as security that the Group is permitted to sell or repledge under these arrangements is described on page 390 of the financial statements.

 

The Group's maximum exposure to credit risk includes financial guarantees and similar contracts granted, as well as loan and other credit-related commitments. Depending on the terms of the arrangement, we may use additional credit mitigation if a guarantee is called upon or a loan commitment is drawn and subsequently defaults.

For further information on these arrangements, see Note 33 on the financial statements.

 

Derivatives

We participate in transactions exposing us to counterparty credit risk. Counterparty credit risk is the risk of financial loss if the counterparty to a transaction defaults before satisfactorily settling it. It arises principally from over-the-counter ('OTC') derivatives and securities financing transactions and is calculated in both the trading and non-trading books. Transactions vary in value by reference to a market factor such as an interest rate, exchange rate or asset price.

The counterparty risk from derivative transactions is taken into account when reporting the fair value of derivative positions. The adjustment to the fair value is known as the credit valuation adjustment ('CVA').

For an analysis of CVAs, see Note 12 on the financial statements.

The following table reflects by risk type the fair values and gross notional contract amounts of derivatives cleared through an exchange, central counterparty or non-central counterparty.

 

Notional contract amounts and fair values of derivatives

2023

20221

Notional amount

Fair value

Notional amount

Fair value

Assets

Liabilities

Assets

Liabilities

$m

$m

$m

$m

$m

$m

Total OTC derivatives

24,551,539

337,066 

343,098 

23,649,591

421,324 

423,909 

- total OTC derivatives cleared by central counterparties

11,130,785

116,520 

118,796 

11,360,730

149,193 

154,167 

- total OTC derivatives not cleared by central counterparties

13,420,754

220,546 

224,302 

12,288,861

272,131 

269,742 

Total exchange traded derivatives

1,111,247

9,134 

8,159 

1,146,426 

3,822 

2,840 

Gross

25,662,786

346,200 

351,258 

24,796,017

425,146 

426,749 

Offset

(116,486)

(116,486)

(140,987)

(140,987)

At 31 Dec

229,714 

234,772 

284,159 

285,762 

1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. We have restated 2022 comparative data.

The purposes for which HSBC uses derivatives are described in Note 15 on the financial statements.

The International Swaps and Derivatives Association ('ISDA') master agreement is our preferred agreement for documenting derivatives activity. It is common, and our preferred practice, for the parties involved in a derivative transaction to execute a credit support annex ('CSA') in conjunction with the ISDA master agreement. Under a CSA, collateral is passed between the parties to mitigate the counterparty risk inherent in outstanding positions. The majority of our CSAs are with financial institutional clients.

We manage the counterparty exposure on our OTC derivative contracts by using collateral agreements with counterparties and netting agreements. Currently, we do not actively manage our general OTC derivative counterparty exposure in the credit markets, although we may manage individual exposures in certain circumstances.

We place strict policy restrictions on collateral types and as a consequence the types of collateral received and pledged are, by value, highly liquid and of a strong quality, being predominantly cash.

Where a collateral type is required to be approved outside the collateral policy, approval is required from a committee of senior representatives from Markets, Legal and Risk.

See Note 31 on the financial statements for details regarding legally enforceable right of offset in the event of counterparty default and collateral received in respect of derivatives.

 

Personal lending

This section presents further disclosures related to personal lending. It provides details of the major legal entities, countries and products that are driving the change observed in personal loans and advances to customers, with the impact of foreign exchange separately identified. Additionally, Hong Kong and UK mortgage book LTV data is provided.

This section also provides reconciliations of the opening 1 January 2023 to 31 December 2023 closing gross carrying/nominal amounts and associated allowance for ECL by product. Further product granularity is also provided by stage, with data for major legal entities presented for loans and advances to customers, loan and other credit-related commitments and financial guarantees.

At 31 December 2023, total personal lending for loans and advances to customers of $447.5bn increased by $32.6bn compared with 31 December 2022. This increase included favourable foreign exchange movements of $11.5bn. Excluding foreign exchange movements, the increase of $21.1bn was mainly driven by growth in the UK (up $6.6bn), in Hong Kong (up $5.8bn), in Mexico (up $2.3bn) and in Australia (up $1.4bn). Additionally, France increased by $7.8bn due to the retention of the home loan portfolio, which is no longer classified as assets held for sale.

The increase was partly offset by a $1.2bn decrease from the merger of our business in Oman and a $1.0bn decrease from the sale of our retail mortgage loan portfolio in New Zealand.

 

The allowance for ECL attributable to personal lending, excluding off-balance sheet loan commitments and guarantees, remained broadly stable at $2.9bn at 31 December 2023, as net releases were offset by adverse foreign exchange movements of $0.1bn.

Excluding foreign exchange movements and reclassifications to held for sale, mortgage lending balances increased by $15.5bn to $360.9bn at 31 December 2023, mainly in Hong Kong (up $5.9bn), in the UK (up $4.9bn), in Mexico (up $1.7bn), in the US (up $1.5bn) and in Australia (up $1.4bn). The allowance for ECL attributable to mortgages remained broadly stable at $0.6bn when compared with 31 December 2022.

Total personal lending gross carrying amounts in stage 2 decreased by $1.4bn compared with 31 December 2022. Excluding favourable foreign exchange movements of $2.3bn, the decrease of $3.7bn was driven by favourable economic conditions and the model updates for interest-only and offset mortgages at a portfolio level in the UK.

 

The quality of both our Hong Kong and UK mortgage books remained strong, with low levels of impairment allowances. The average LTV ratio on new mortgage lending in Hong Kong was 64%, compared with an estimated 60% for the overall mortgage portfolio. The average LTV ratio on new lending in the UK was 65%, compared with an estimated 53% for the overall mortgage portfolio.

Excluding foreign exchange movements and reclassifications to held for sale, other personal lending balances at 31 December 2023 increased by $7.8bn compared with 31 December 2022. This was mainly from the retained home loan portfolio in France (up $7.4bn), which is no longer classified as assets held for sale. In addition, our credit card portfolio in Mexico increased by $0.6bn.

The allowance for ECL, excluding foreign exchange movements, attributable to other personal lending of $2.3bn remained unchanged from 31 December 2022. The allowance for ECL attributable to credit cards decreased by $0.1bn, offset by adverse foreign exchange movements of $0.1bn in other personal lending.

 

Total personal lending for loans and advances to customers at amortised cost by stage distribution

Gross carrying amount

Allowance for ECL

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

$m

$m

$m

$m

$m

$m

$m

$m

By portfolio

First lien residential mortgages

320,410 

38,287 

2,212 

360,909 

(102)

(200)

(269)

(571)

- of which: interest-only (including offset)

21,895 

2,923 

139 

24,957 

(4)

(27)

(31)

(62)

- affordability (including US adjustable rate mortgages)

14,380 

381 

291 

15,052 

(3)

(1)

(10)

(14)

Other personal lending

76,124 

9,196 

1,293 

86,613 

(477)

(1,234)

(585)

(2,296)

- second lien residential mortgages

317 

58 

21 

396 

(3)

(5)

(8)

- guaranteed loans in respect of residential property

8,001 

502 

90 

8,593 

(1)

(5)

(14)

(20)

- other personal lending which is secured

28,900 

424 

157 

29,481 

(13)

(5)

(24)

(42)

- credit cards

19,909 

4,419 

352 

24,680 

(236)

(697)

(203)

(1,136)

- other personal lending which is unsecured

17,010 

3,582 

659 

21,251 

(212)

(505)

(331)

(1,048)

- motor vehicle finance

1,987 

211 

14 

2,212 

(15)

(19)

(8)

(42)

At 31 Dec 2023

396,534 

47,483 

3,505 

447,522 

(579)

(1,434)

(854)

(2,867)

By legal entity

HSBC UK Bank plc

146,354 

35,190 

1,218 

182,762 

(152)

(490)

(255)

(897)

HSBC Bank plc

14,598 

1,747 

273 

16,618 

(24)

(22)

(91)

(137)

The Hongkong and Shanghai Banking Corporation Limited

191,382 

7,741 

948 

200,071 

(165)

(402)

(162)

(729)

HSBC Bank Middle East Limited

3,335 

397 

47 

3,779 

(19)

(33)

(36)

(88)

HSBC North America Holdings Inc.

18,096 

553 

364 

19,013 

(5)

(14)

(16)

(35)

Grupo Financiero HSBC, S.A. de C.V.

12,717 

1,740 

536 

14,993 

(197)

(463)

(273)

(933)

Other trading entities

10,052 

115 

119 

10,286 

(17)

(10)

(21)

(48)

At 31 Dec 2023

396,534 

47,483 

3,505 

447,522 

(579)

(1,434)

(854)

(2,867)

 

Total personal lending for loans and other credit-related commitments and financial guarantees by stage distribution

Nominal amount

Allowance for ECL

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

$m

$m

$m

$m

$m

$m

$m

$m

HSBC UK Bank plc

52,093 

734 

88 

52,915 

(11)

(2)

(13)

HSBC Bank plc

1,630 

36 

1,670 

The Hongkong and Shanghai Banking Corporation Limited

181,967 

2,479 

223 

184,669 

(3)

(3)

HSBC Bank Middle East Limited

1,978 

1,986 

HSBC North America Holdings Inc.

3,695 

72 

3,775 

HSBC Bank Canada

6,610 

113 

30 

6,753 

Grupo Financiero HSBC, S.A. de C.V.

4,308 

4,308 

(8)

(8)

Other trading entities

2,008 

31 

2,040 

(1)

(1)

At 31 Dec 2023

254,289 

3,472 

355 

258,116 

(23)

(2)

(25)

 

Total personal lending for loans and advances to customers at amortised cost by stage distribution (continued)

Gross carrying amount

Allowance for ECL

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

$m

$m

$m

$m

$m

$m

$m

$m

By portfolio

First lien residential mortgages

294,919 

39,860 

2,042 

336,821 

(74)

(231)

(270)

(575)

- of which: interest-only (including offset)

19,636 

4,485 

169 

24,290 

(3)

(46)

(41)

(90)

- affordability (including US adjustable rate mortgages)

14,773 

369 

240 

15,382 

(5)

(3)

(4)

(12)

Other personal lending

67,758 

9,006 

1,297 

78,061 

(487)

(1,273)

(535)

(2,295)

- second lien residential mortgages

353 

20

6

379 

(1)

(2)

(3)

(6)

- guaranteed loans in respect of residential property

1,121 

121 

125 

1,367 

(1)

(3)

(30)

(34)

- other personal lending which is secured

31,306 

594 

206 

32,106 

(15)

(10)

(30)

(55)

- credit cards

16,705 

4,423 

260 

21,388 

(225)

(776)

(160)

(1,161)

- other personal lending which is unsecured

16,512 

3,681 

687 

20,880 

(234)

(469)

(305)

(1,008)

- motor vehicle finance

1,761 

167 

13

1,941 

(11)

(13)

(7)

(31)

At 31 Dec 2022

362,677 

48,866 

3,339 

414,882 

(561)

(1,504)

(805)

(2,870)

By legal entity

HSBC UK Bank plc

128,590 

37,394 

1,012 

166,996 

(135)

(688)

(227)

(1,050)

HSBC Bank plc

6,377 

740 

127 

7,244 

(10)

(18)

(38)

(66)

The Hongkong and Shanghai Banking Corporation Limited

185,723 

8,698 

1,117 

195,538 

(138)

(362)

(187)

(687)

HSBC Bank Middle East Limited

3,657 

184 

86

3,927 

(26)

(37)

(52)

(115)

HSBC North America Holdings Inc.

16,906 

375 

270 

17,551 

(12)

(23)

(6)

(41)

Grupo Financiero HSBC, S.A. de C.V.

9,542 

1,099 

377 

11,018 

(213)

(331)

(194)

(738)

Other trading entities

11,882 

376 

350 

12,608 

(27)

(45)

(101)

(173)

At 31 Dec 2022

362,677 

48,866 

3,339 

414,882 

(561)

(1,504)

(805)

(2,870)

 

Total personal lending for loans and other credit-related commitments and financial guarantees by stage distribution (continued)

Nominal amount

Allowance for ECL

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

$m

$m

$m

$m

$m

$m

$m

$m

HSBC UK Bank plc

50,535 

439 

104 

51,078 

(11)

(1)

(12)

HSBC Bank plc

2,440 

131 

7

2,578 

The Hongkong and Shanghai Banking Corporation Limited

170,104 

2,916 

634 

173,654 

(2)

(2)

HSBC Bank Middle East Limited

1,717 

8

1

1,726 

(1)

(1)

HSBC North America Holdings Inc.

3,914 

24

17

3,955 

(1)

(1)

HSBC Bank Canada

6,346 

115 

30

6,491 

Grupo Financiero HSBC, S.A. de C.V.

3,198 

3,198 

(9)

(9)

Other trading entities

2,390 

64

7

2,461 

(2)

(2)

At 31 Dec 2022

240,644 

3,697 

800 

245,141 

(26)

(1)

(27)

 

Exposure to UK interest-only mortgage loans

The following information is presented for HSBC branded interest-only mortgage loans. This excludes offset mortgages in first direct and private banking mortgages.

At the end of 2023, the average LTV ratio of the interest-only mortgage loans was 44% (2022: 41%), and 97% (2022: 99%) had an LTV ratio of 75% or less.

 

Of the interest-only mortgage loans that expired in 2021, 82% were repaid within 12 months of expiry with a total of 96% being repaid within 24 months of expiry. For those expiring during 2022, 92% were repaid within 12 months of expiry.

At 31 December 2023, interest-only mortgage loan exposures were $15.2bn (2022: $14.4bn) and the maturity profile was as follows:

UK interest-only mortgage loans

$m

Expired interest-only mortgage loans

141 

Interest-only mortgage loans by maturity

- 2024

141 

- 2025

242 

- 2026

315 

- 2027

436 

- 2028-2032

2,919 

- post-2032

11,010 

At 31 Dec 2023

15,204 

 

UK interest-only mortgage loans (continued)

$m

Expired interest-only mortgage loans

134 

Interest-only mortgage loans by maturity

- 2023

219 

- 2024

215 

- 2025

300 

- 2026

383 

- 2027-2031

2,951 

- post-2031

10,248 

At 31 Dec 2022

14,450 

 

Exposure to offset mortgage in first direct

The offset mortgage in first direct is a flexible way for our customers to take control of their finances. It works by grouping together the customer's mortgage, savings and current accounts to offset their credit and debit balances against their mortgage exposure. At 31 December 2023, exposures were worth a total $5.0bn with an average LTV ratio of 29% (2022: $5.5bn exposure and 32% LTV ratio).

Reconciliations of changes in personal lending gross carrying/nominal amount and allowances for loans and advances to customers including loan commitments and financial guarantees

The following disclosure provides a reconciliation by stage of the Group's personal lending gross carrying/nominal amount and allowances for loans and advances to customers, including loan commitments and financial guarantees.

In addition, three reconciliations by stage of the Group's gross carrying/nominal amount and allowances for first lien mortgages, credit cards and other personal lending, including loan commitments and financial guarantees were added at 31 December 2023 following the adoption of the recommendations of the DECL Taskforce's third report.

Personal lending - reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to customers

including loan commitments and financial guarantees

(Audited)

Non-credit impaired

Credit impaired

Stage 1

Stage 2

Stage 3

Total

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

$m

$m

$m

$m

$m

$m

$m

$m

At 1 Jan 2023

603,321 

(587)

52,563 

(1,505)

4,139 

(805)

660,023 

(2,897)

Transfers of financial instruments:

(2,144)

(619)

39 

1,087 

2,105 

(468)

- transfers from stage 1 to stage 2

(57,217)

270 

57,217 

(270)

-

-

- transfers from stage 2 to stage 1

55,307 

(862)

(55,307)

862 

- transfers to stage 3

(542)

(2,345)

614 

2,887 

(617)

-

- transfers from stage 3

308 

(30)

474 

(119)

(782)

149 

-

Net remeasurement of ECL arising from transfer of stage

563 

(679)

(79)

(195)

Net new and further lending/repayments

34,411 

(47)

(4,713)

350 

(1,169)

144 

28,529 

447 

Change to risk parameters - credit quality

104 

(641)

(955)

(1,492)

Changes to models used for ECL calculation

(13)

21 

15 

Assets written off

(1,326)

1,326 

(1,326)

1,326 

Foreign exchange and others1,2

15,235 

(3)

3,066 

(67)

111 

(26)

18,412 

(96)

At 31 Dec 2023

650,823 

(602)

50,955 

(1,434)

3,860 

(856)

705,638 

(2,892)

ECL income statement change for the period

607 

(949)

(883)

(1,225)

Recoveries

226 

Others

Total ECL income statement change for the period

(991)

1 Total includes $7.8bn of gross carrying loans and advances and a corresponding allowance for ECL of $11m, due to the retention of certain balances previously classified as assets held for sale of our retail banking operations in France. For further details, see Note 23 'Assets held for sale and liabilities of disposal groups held for sale' on page 401.

2 Total includes $2.0bn of gross carrying loans and advances to customers, which were classified to assets held for sale, and a corresponding allowance for ECL of $20m, reflecting business disposals, as disclosed in Note 23 'Assets held for sale and liabilities of disposal groups held for sale' on page 401.

As shown in the above table, the allowance for ECL for loans and advances to customers and relevant loan commitments and financial guarantees decreased by $5m during the period from $2,897m at 31 December 2022 to $2,892m at 31 December 2023.

 

This decrease was driven by:

- $1,326m of assets written off;

- $447m relating to volume movements, which included the allowance for ECL associated with new originations, assets derecognised and further lending/repayment; and

- $15m of changes to models used for ECL calculation.

 

These were partly offset by:

- $1,492m relating to underlying credit quality changes, including the credit quality impact of financial instruments transferring between stages;

- $195m relating to the net remeasurement impact of stage transfers; and

- foreign exchange and other movements of $96m.

The ECL charge for the period of $1,225m presented in the above table consisted of $1,492m relating to underlying credit quality changes, including the credit quality impact of financial instruments transferring between stages, and $195m relating to the net remeasurement impact of stage transfers. This was partly offset by $447m relating to underlying net book volume movements and $15m in changes to models used for the calculation of ECL.

During the period, there was a net transfer to stage 2 of $1,910m gross carrying/nominal amounts. This increase was mainly driven by $1,550m in Mexico, due to slight deterioration in the unsecured portfolio.

 

Personal lending - reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to customers

including loan commitments and financial guarantees

(Audited)

Non-credit impaired

Credit impaired

Stage 1

Stage 2

Stage 3

Total

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

$m

$m

$m

$m

$m

$m

$m

$m

At 1 Jan 2022

695,627 

(692)

18,161 

(1,220)

5,111 

(1,226)

718,899 

(3,138)

Transfers of financial instruments:

(40,836)

(496)

39,489 

674 

1,347 

(178)

- transfers from stage 1 to stage 2

(68,016)

268 

68,016 

(268)

- transfers from stage 2 to stage 1

27,359 

(730)

(27,359)

730 

- transfers to stage 3

(561)

2

(1,983)

361 

2,544 

(363)

- transfers from stage 3

382 

(36)

815 

(149)

(1,197)

185 

Net remeasurement of ECL arising from transfer of stage

495 

(579)

(85)

(169)

Net new and further lending/repayments

30,637 

(17)

459 

234 

(146)

91

30,950 

308 

Change to risk parameters - credit quality

82

(676)

(823)

(1,417)

Changes to models used for ECL calculation

(2)

(95)

13

(84)

Assets written off

(1,212)

1,212 

(1,212)

1,212 

Foreign exchange and others1

(82,107)

43

(5,546)

157 

(961)

191 

(88,614)

391 

At 31 Dec 2022

603,321 

(587)

52,563 

(1,505)

4,139 

(805)

660,023 

(2,897)

ECL income statement change for the period

558 

(1,116)

(804)

(1,362)

Recoveries

283 

Others

(3)

Total ECL income statement change for the period

(1,082)

1 Total includes $49.6bn of gross carrying loans and advances to customers, which were classified to assets held for sale, and a corresponding allowance for ECL of $221m, reflecting business disposals, as disclosed in Note 23 'Assets held for sale and liabilities of disposal groups held for sale' on page 401.

First lien residential mortgages - reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to customers including loan commitments and financial guarantees

Non-credit impaired

Credit impaired

Stage 1

Stage 2

Stage 3

Total

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

$m

$m

$m

$m

$m

$m

$m

$m

At 1 Jan 2023

317,666 

(74)

40,048 

(231)

2,230 

(270)

359,944 

(575)

Transfers of financial instruments:

(1,182)

(109)

421 

138 

761 

(29)

- transfers from stage 1 to stage 2

(41,207)

28 

41,207 

(28)

-

-

- transfers from stage 2 to stage 1

40,164 

(117)

(40,164)

117 

- transfers to stage 3

(354)

(958)

100 

1,312 

(101)

-

- transfers from stage 3

215 

(21)

336 

(51)

(551)

72 

-

Net remeasurement of ECL arising from transfer of stage

72 

(79)

(67)

(74)

Net new and further lending/repayments

15,447 

(3)

(3,939)

22 

(751)

322 

10,757 

341 

Change to risk parameters - credit quality

16 

(67)

(269)

(320)

Changes to models used for ECL calculation

(2)

28 

26 

Assets written off

(53)

53 

(53)

53 

Foreign exchange and others

8,833 

(9)

1,983 

(13)

71 

(4)

10,887 

(26)

At 31 Dec 2023

340,764 

(109)

38,513 

(202)

2,258 

(264)

381,535 

(575)

ECL income statement change for the period

83 

(96)

(14)

(27)

Recoveries

10 

Others

13 

Total ECL income statement change for the period

(4)

 

Credit cards - reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to customers including loan commitments and financial guarantees

Non-credit impaired

Credit impaired

Stage 1

Stage 2

Stage 3

Total

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

$m

$m

$m

$m

$m

$m

$m

$m

At 1 Jan 2023

140,519 

(244)

6,747 

(777)

353 

(160)

147,619 

(1,181)

Transfers of financial instruments:

199 

(292)

(848)

496 

649 

(204)

- transfers from stage 1 to stage 2

(7,855)

102 

7,855 

(102)

-

- transfers from stage 2 to stage 1

8,124 

(391)

(8,124)

391 

- transfers to stage 3

(82)

(621)

227 

703 

(228)

- transfers from stage 3

12 

(4)

42 

(20)

(54)

24 

-

Net remeasurement of ECL arising from transfer of stage

185 

(301)

(5)

(121)

Net new and further lending/repayments

13,206 

27 

621 

169 

12 

(41)

13,839 

155 

Change to risk parameters - credit quality

82 

(281)

(301)

(500)

Changes to models used for ECL calculation

(9)

15 

Assets written off

(571)

571 

(571)

571 

Foreign exchange and others

(632)

(2)

27 

(19)

(5)

(598)

(26)

At 31 Dec 2023

153,292 

(253)

6,547 

(698)

450 

(144)

160,289 

(1,095)

ECL income statement change for the period

285 

(398)

(346)

(459)

Recoveries

108 

Others

(200)

Total ECL income statement change for the period

(551)

 

Other personal lending - reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to

customers including loan commitments and financial guarantees

Non-credit impaired

Credit impaired

Stage 1

Stage 2

Stage 3

Total

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

Gross carrying/ nominal amount

Allowance for ECL

$m

$m

$m

$m

$m

$m

$m

$m

At 1 Jan 2023

145,136 

(269)

5,768 

(497)

1,556 

(375)

152,460 

(1,141)

Transfers of financial instruments:

(1,161)

(218)

466 

453 

695 

(235)

- transfers from stage 1 to stage 2

(8,155)

140 

8,155 

(140)

- transfers from stage 2 to stage 1

7,019 

(354)

(7,019)

354 

- transfers to stage 3

(106)

(766)

287 

872 

(288)

-

-

- transfers from stage 3

81 

(5)

96 

(48)

(177)

53 

-

Net remeasurement of ECL arising from transfer of stage

306 

(299)

(7)

-

Net new and further lending/repayments

5,758 

(71)

(1,395)

159 

(430)

(137)

3,933 

(49)

Change to risk parameters - credit quality

(293)

(385)

(672)

Changes to models used for ECL calculation

(2)

(22)

(18)

Assets written off

(702)

702 

(702)

702 

Foreign exchange and others1

7,034 

1,056 

(35)

33 

(17)

8,123 

(44)

At 31 Dec 2023

156,767 

(240)

5,895 

(534)

1,152 

(448)

163,814 

(1,222)

ECL income statement change for the period

239 

(455)

(523)

(739)

Recoveries

108 

Others

195 

Total ECL income statement change for the period

(436)

1 Total includes $7.2bn of gross carrying loans and advances and a corresponding allowance for ECL of $10m, due to the retention of certain balances previously classified as assets held for sale of our retail banking operations in France. For further details, see Note 23 'Assets held for sale and liabilities of disposal groups held for sale' on page 401.

Personal lending - credit risk profile by internal PD band for loans and advances to customers at amortised cost

Gross carrying amount

Allowance for ECL

PD range1

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

ECL coverage

%

$m

$m

$m

$m

$m

$m

$m

$m

%

First lien residential mortgages2

320,410 

38,287 

2,212 

360,909 

(102)

(200)

(269)

(571)

0.2

- Band 1

0.000 to 0.250

229,188 

3,174 

232,362 

(16)

(14)

(30)

-

- Band 2

0.251 to 0.500

54,891 

12,266 

67,157 

(11)

(17)

(28)

-

- Band 3

0.501 to 1.500

28,159 

16,140 

44,299 

(22)

(49)

(71)

0.2

- Band 4

1.501 to 5.000

7,451 

4,559 

12,010 

(52)

(30)

(82)

0.7

- Band 5

5.001 to 20.000

599 

1,097 

1,696 

-

(11)

(11)

0.6

- Band 6

20.001 to 99.999

122 

1,051 

1,173 

(1)

(79)

(80)

6.8

- Band 7

100.000

2,212 

2,212 

(269)

(269)

12.2

Credit cards

19,909 

4,419 

352 

24,680 

(236)

(697)

(203)

(1,136)

4.6

- Band 1

0.000 to 0.250

9,490 

9,491 

(32)

-

-

(32)

0.3

- Band 2

0.251 to 0.500

2,481 

2,487 

(21)

(1)

(22)

0.9

- Band 3

0.501 to 1.500

4,799 

294 

5,093 

(56)

(17)

(73)

1.4

- Band 4

1.501 to 5.000

2,787 

2,291 

5,078 

(93)

(158)

(251)

4.9

- Band 5

5.001 to 20.000

352 

1,374 

1,726 

(34)

(258)

(292)

16.9

- Band 6

20.001 to 99.999

453 

453 

-

(263)

(263)

58.1

- Band 7

100.000

352 

352 

(203)

(203)

57.7

Other personal lending (excluding credit cards)

56,215 

4,777 

941 

61,933 

(241)

(537)

(382)

(1,160)

1.9

- Band 1

0.000 to 0.250

28,115 

30 

28,145 

(34)

(1)

-

(35)

0.1

- Band 2

0.251 to 0.500

6,634 

286 

6,920 

(11)

(1)

(12)

0.2

- Band 3

0.501 to 1.500

12,935 

329 

13,264 

(61)

(9)

(70)

0.5

- Band 4

1.501 to 5.000

7,215 

1,447 

8,662 

(79)

(46)

(125)

1.4

- Band 5

5.001 to 20.000

1,137 

2,005 

3,142 

(55)

(199)

(254)

8.1

- Band 6

20.001 to 99.999

179 

680 

859 

(1)

(281)

(282)

32.8

- Band 7

100.000

941 

941 

(382)

(382)

40.6

At 31 Dec 2023

396,534 

47,483 

3,505 

447,522 

(579)

(1,434)

(854)

(2,867)

0.6

 

First lien residential mortgages2

294,919 

39,860 

2,042 

336,821 

(74)

(231)

(270)

(575)

0.2

- Band 1

0.000 to 0.250

247,330 

21,220 

268,550 

(13)

(4)

(17)

-

- Band 2

0.251 to 0.500

19,615 

7,900 

27,515 

(4)

(3)

(7)

-

- Band 3

0.501 to 1.500

21,323 

5,691 

27,014 

(18)

(7)

(25)

0.1

- Band 4

1.501 to 5.000

6,594 

2,694 

9,288 

(39)

(24)

(63)

0.7

- Band 5

5.001 to 20.000

34

1,024 

1,058 

(40)

(40)

3.8

- Band 6

20.001 to 99.999

23

1,331 

1,354 

(153)

(153)

11.3

- Band 7

100.000

2,042 

2,042 

(270)

(270)

13.2

Other personal lending

67,758 

9,006 

1,297 

78,061 

(487)

(1,273)

(535)

(2,295)

2.9

- Band 1

0.000 to 0.250

30,150 

153 

30,303 

(54)

(13)

(67)

0.2

- Band 2

0.251 to 0.500

7,219 

251 

7,470 

(26)

(1)

(27)

0.4

- Band 3

0.501 to 1.500

17,077 

1,499 

18,576 

(82)

(44)

(126)

0.7

- Band 4

1.501 to 5.000

10,344 

2,036 

12,380 

(170)

(103)

(273)

2.2

- Band 5

5.001 to 20.000

2,501 

3,692 

6,193 

(154)

(520)

(674)

10.9

- Band 6

20.001 to 99.999

467 

1,375 

1,842 

(1)

(592)

(593)

32.2

- Band 7

100.000

1,297 

1,297 

(535)

(535)

41.2

At 31 Dec 2022

362,677 

48,866 

3,339 

414,882 

(561)

(1,504)

(805)

(2,870)

0.7

1 12-month point in time adjusted for multiple economic scenarios.

2 PD bands do not consider the impact of any management judgemental adjustments on stage or allowances for ECL including the impact of new models not yet formally implemented. For a list of management judgemental adjustments see page 163.

Personal lending - credit risk profile by internal PD band for loan and other credit-related commitments and financial guarantees

Nominal amount

Allowance for ECL

PD range1

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

ECL coverage

%

$m

$m

$m

$m

$m

$m

$m

$m

%

Loan and other credit-related commitments

253,183 

3,459 

355 

256,997 

(23)

(2)

(25)

-

- Band 1

0.000 to 0.250

196,201 

114 

-

196,315 

(15)

-

(15)

-

- Band 2

0.251 to 0.500

17,861 

63 

17,924 

(1)

-

(1)

-

- Band 3

0.501 to 1.500

29,623 

1,262 

30,885 

(1)

-

(1)

-

- Band 4

1.501 to 5.000

8,550 

1,334 

9,884 

(4)

-

(4)

-

- Band 5

5.001 to 20.000

508 

564 

1,072 

(2)

-

(2)

0.2

- Band 6

20.001 to 99.999

440 

122 

562 

-

-

-

-

- Band 7

100.000

355 

355 

-

(2)

(2)

0.6

Financial guarantees

1,106 

13 

1,119 

-

- Band 1

0.000 to 0.250

348 

348 

-

-

- Band 2

0.251 to 0.500

386 

386 

-

-

- Band 3

0.501 to 1.500

359 

360 

-

-

-

- Band 4

1.501 to 5.000

-

-

-

- Band 5

5.001 to 20.000

12 

14 

-

-

-

- Band 6

20.001 to 99.999

-

- Band 7

100.000

-

-

At 31 Dec 2023

254,289 

3,472 

355 

258,116 

(23)

(2)

(25)

-

1 12-month point in time adjusted for multiple economic scenarios.

Collateral on loans and advances

(Audited)

The following table provides a quantification of the value of fixed charges we hold over specific assets where we have a history of enforcing, and are able to enforce, collateral in satisfying a debt in the event of the borrower failing to meet its contractual obligations, and where the collateral is cash or can be realised by sale in an

established market. The collateral valuation excludes any adjustments for obtaining and selling the collateral and, in particular, loans shown as not collateralised or partially collateralised may also benefit from other forms of credit mitigants.

Personal lending - residential mortgage loans including loan commitments by level of collateral for key countries/territories by stage

(Audited)

Gross carrying/nominal amount

ECL coverage

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

$m

$m

$m

$m

%

%

%

%

Fully collateralised by LTV ratio

331,279 

38,378 

2,129 

371,786 

-

0.5

10.1

0.1

- less than 50%

140,992 

19,715 

1,165 

161,872 

0.3

7.1

0.1

- 51% to 70%

113,043 

12,636 

568 

126,247 

-

0.6

10.9

0.1

- 71% to 80%

37,866 

4,111 

229 

42,206 

-

0.9

15.2

0.2

- 81% to 90%

23,278 

1,499 

109 

24,886 

-

1.2

17.3

0.2

- 91% to 100%

16,100 

417 

58 

16,575 

-

1.6

28.9

0.2

Partially collateralised (A): LTV > 100%

9,529 

136 

129 

9,794 

-

3.4

42.0

0.6

- collateral value on A

8,968 

123 

104 

9,195 

Total at 31 Dec 2023

340,808 

38,514 

2,258 

381,580 

-

0.5

11.9

0.1

of which: UK

Fully collateralised by LTV ratio

146,739 

33,597 

759 

181,095 

-

0.3

9.7

0.1

- less than 50%

60,403 

17,629 

458 

78,490 

0.2

7.9

0.1

- 51% to 70%

49,945 

11,248 

207 

61,400 

-

0.4

9.4

0.1

- 71% to 80%

20,293 

3,275 

61 

23,629 

-

0.6

13.4

0.1

- 81% to 90%

12,946 

1,161 

18 

14,125 

-

0.8

17.5

0.1

- 91% to 100%

3,152 

284 

15 

3,451 

-

1.0

41.6

0.3

Partially collateralised (B): LTV > 100%

317 

19 

27 

363 

0.1

1.7

17.5

1.4

- collateral value on B

244 

15 

22 

281 

Total UK at 31 Dec 2023

147,056 

33,616 

786 

181,458 

-

0.3

9.9

0.1

of which: Hong Kong

Fully collateralised

97,414 

1,354 

93 

98,861 

-

-

0.3

-

- less than 50%

41,903 

831 

66 

42,800 

-

0.1

-

- 51% to 70%

29,762 

330 

15 

30,107 

-

-

0.5

-

- 71% to 80%

5,260 

48 

5,310 

-

0.1

0.4

-

- 81% to 90%

8,161 

61 

8,226 

-

0.1

1.9

-

- 91% to 100%

12,328 

84 

12,418 

-

0.3

1.8

-

Partially collateralised (C): LTV > 100%

8,973 

86 

9,063 

-

0.9

7.8

-

- collateral value on C

8,535 

81 

8,620 

Total Hong Kong at 31 Dec 2023

106,387 

1,440 

97 

107,924 

-

0.1

0.7

-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSEAEAFAAKLEFA
Date   Source Headline
8th May 20245:40 pmRNSTransaction in Own Shares
8th May 20247:00 amRNSHSBC tender offers for four series of notes
7th May 202410:30 amRNSHSBC Holdings plc – Share buy-back
3rd May 20243:20 pmRNSAGM poll results + changes Board+Ctte composition
3rd May 202411:06 amRNSHSBC Holdings plc - AGM Statements
1st May 20244:30 pmRNSDirector Declaration
1st May 20244:00 pmRNSPublication of base prospectus supplement
30th Apr 20244:15 pmRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSHSBC Holdings 1Q 2024 webcast presentation
30th Apr 20247:00 amRNSRetirement of Group Chief Executive
30th Apr 20247:00 amRNSHSBC Holdings 1Q24 earnings release
29th Apr 20244:30 pmRNSTotal Voting Rights
29th Apr 20244:15 pmRNSDirector/PDMR Shareholding
23rd Apr 20246:04 pmRNSTransaction in Own Shares & Conclusion of Buy-Back
22nd Apr 20245:59 pmRNSTransaction in Own Shares
19th Apr 20245:57 pmRNSTransaction in Own Shares
19th Apr 20248:40 amRNSPost Stabilisation Notice
18th Apr 20245:58 pmRNSTransaction in Own Shares
18th Apr 202410:00 amRNSOverseas Regulatory Announcement - Board Meeting
17th Apr 20246:15 pmRNSTransaction in Own Shares
16th Apr 20246:00 pmRNSTransaction in Own Shares
15th Apr 20246:24 pmRNSTransaction in Own Shares
15th Apr 20241:00 pmRNSFourth Interim Dividend for 2023 - Exchange Rate
12th Apr 20245:57 pmRNSTransaction in Own Shares
12th Apr 20243:35 pmRNSNotice of redemption
11th Apr 20246:25 pmRNSTransaction in Own Shares
11th Apr 202410:00 amRNSOverseas Regulatory Announcement - Grant of Awards
10th Apr 20246:09 pmRNSTransaction in Own Shares
9th Apr 20245:53 pmRNSTransaction in Own Shares
9th Apr 20247:00 amRNSHSBC AGREES TO SELL ITS BUSINESS IN ARGENTINA
8th Apr 20246:10 pmRNSTransaction in Own Shares
5th Apr 202410:00 amRNSDirector Declaration
4th Apr 20246:24 pmRNSTransaction in Own Shares
3rd Apr 20246:14 pmRNSTransaction in Own Shares
2nd Apr 20245:59 pmRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSCompletion of the sale of HSBC Bank Canada to RBC
28th Mar 20246:01 pmRNSTransaction in Own Shares
28th Mar 20244:30 pmRNSDirector/PDMR Shareholding
28th Mar 20244:00 pmRNSTotal Voting Rights
27th Mar 20245:58 pmRNSTransaction in Own Shares
27th Mar 20243:45 pmRNSPublication of base prospectus
26th Mar 20245:54 pmRNSTransaction in Own Shares
25th Mar 20245:58 pmRNSTransaction in Own Shares
22nd Mar 20245:50 pmRNSTransaction in Own Shares
22nd Mar 20242:00 pmRNSIssuance of subordinated unsecured notes
22nd Mar 202410:00 amRNS2024 AGM - Documents available at NSM
21st Mar 20246:03 pmRNSTransaction in Own Shares
21st Mar 202411:00 amRNSIssuance of subordinated unsecured notes
20th Mar 20245:51 pmRNSTransaction in Own Shares
20th Mar 202410:00 amRNSHong Kong Waiver-Contingent Convertible Securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.